Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035062	maksa-1-is	U/l (u/l)	909	1031	0.00%
3035062	afosmaksa1	U/l (u/l)	589	673	0.00%
3035062	afosmaksa1	— (—)	182	194	100.00%	Distribution not available
3035062	s-afmaks1	U/l (u/l)	173	199	0.00%
3035062	s-maksa-1-isoentsyymi	U/l (u/l)	165	178	0.00%
3035062	s-maksa1	U/l (u/l)	126	134	0.00%
3035062	s-maksa-1	U/l (u/l)	104	115	0.00%
3035062	maksa-1-isoentsyymi	U/l (u/l)	90	92	0.00%
3035062	s-afos1ma	U/l (u/l)	68	77	0.00%
3035062	maksa-1-is	— (—)	66	72	100.00%	Distribution not available
3035062	s-maksa-1-isoentsyymi	— (—)	25	28	100.00%	Distribution not available
3035062	maksa-1-ls	U/l (u/l)	18	22	0.00%
3035062	s-maksa-1-isoentsyymi	U/L (u/l)	11	11	0.00%	Distribution not available
3035062	s-maksa1	— (—)	9	9	100.00%	Distribution not available
3035062	maksa-1-isoentsyymi	— (—)	9	9	100.00%	Distribution not available
3035062	s-maksa-1	— (—)	6	6	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

418

818

5.21

200.76

1.2

1.1

106.89

79.92

u/l

6.58

373

737

Care involving dialysis

173

123

14.76

191.22

1.3

1.1

84.10

98.22

u/l

0.57

168

109

Chronic kidney disease

375

679

5.41

185.59

1.2

1.1

101.66

83.97

u/l

2.12

355

586

Abnormal findings on examination of blood, without diagnosis

466

997

4.29

171.92

1.2

1.1

93.57

83.78

u/l

1.54

433

874

Dialysis, with operation codes

205

233

9.10

165.40

1.2

1.1

97.42

84.29

u/l

0.71

199

210

Renal failure

466

969

4.15

161.74

1.2

1.1

102.20

83.33

u/l

2.87

435

835

ILD medications: immunosuppressive drugs

530

1353

3.58

152.94

1.2

1.1

80.87

82.19

u/l

0.12

498

1177

All chronic kidney diseases

488

1028

3.83

148.92

1.2

1.1

99.49

79.20

u/l

3.57

457

890

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

728

1633

3.03

147.90

1.2

1.1

95.83

78.25

u/l

4.45

663

1441

Nephropathy related operations

195

240

8.40

147.65

1.2

1.1

100.88

89.75

u/l

0.54

189

216

Anaemias

203

125

10.54

143.83

1.3

1.2

95.83

65.76

u/l

2.56

185

116

Other diseases of liver

247

416

6.08

139.90

1.2

1.1

102.87

77.38

u/l

4.03

216

375

Autoimmune diseases excluding thyroid diseases

694

1223

3.09

136.25

1.2

1.1

83.94

81.59

u/l

0.29

643

1074

Any gastric operation

436

496

4.43

134.14

1.2

1.1

82.17

64.76

u/l

3.90

395

413

GASTRO-related operations

436

496

4.43

134.14

1.2

1.1

82.17

64.76

u/l

3.90

395

413

Autoimmune diseases excluding thyroid diseases, strict definition

667

1172

3.11

132.50

1.2

1.1

82.14

81.95

u/l

0.02

616

1031

Abnormal serum enzyme levels

306

637

4.71

129.56

1.2

1.1

94.39

89.03

u/l

0.42

292

561

Renal tubulo-interstitial diseases

642

1633

2.90

124.42

1.2

1.1

99.09

77.01

u/l

5.83

596

1433

Transplanted organ and tissue status

146

166

9.07

117.75

1.3

1.1

94.83

87.40

u/l

0.31

140

150

Autoimmune diseases related-to ILD

602

1818

2.78

112.15

1.2

1.1

79.83

84.30

u/l

0.62

556

1605

All kidney diseases

660

1645

2.70

109.88

1.2

1.1

94.77

77.11

u/l

4.31

611

1446

First line medication for Crohn's disease

684

1360

2.72

107.73

1.2

1.1

84.31

82.09

u/l

0.24

643

1176

Primary biliary cholangitis, wide definition

22.38

106.84

1.2

1.0

117.16

98.58

u/l

0.59

Glomerular diseases

206

387

5.43

103.92

1.2

1.1

101.52

84.35

u/l

1.11

196

345

Fibrosis and cirrhosis of liver

136

166

8.51

103.86

1.1

121.53

72.05

u/l

8.10

123

149

Glomerular disorders in diseases classified elsewhere

159

234

6.98

102.92

1.2

1.1

106.24

87.95

u/l

0.85

151

208

Autoimmune diseases

656

1238

2.70

100.26

1.2

1.1

86.24

81.34

u/l

0.62

599

1089

ILD medications

694

1450

2.59

100.03

1.2

1.1

85.15

82.49

u/l

0.31

647

1262

ILD medications: prednisolone, methylprednisolone, prednisone

675

1443

2.61

99.78

1.2

1.1

87.36

82.54

u/l

0.65

632

1256

Other bacterial diseases

634

1621

2.61

98.08

1.2

1.1

97.10

77.66

u/l

4.82

576

1435

Fever of other and unknown origin

411

1137

3.15

96.46

1.2

1.1

104.79

80.46

u/l

3.52

374

1024

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

623

1527

2.59

94.20

1.2

1.1

83.25

81.37

u/l

0.21

553

1368

Primary biliary cholangitis (PBC)

20.82

92.02

1.2

1.0

120.74

101.78

u/l

0.56

Inflammatory bowel disease treatment related agents

699

1590

2.45

90.89

1.2

1.1

84.88

82.64

u/l

0.26

647

1393

Used for control exclusion in common control thyroid runs

591

1106

2.71

90.50

1.2

1.1

85.53

81.50

u/l

0.42

540

977

Insulin, fast-acting

291

799

3.68

90.07

1.2

1.1

109.79

79.76

u/l

3.31

263

707

Other bacterial diseases, including avohilmo

641

1619

2.48

88.75

1.2

1.1

93.99

77.21

u/l

4.34

582

1437

Other septicaemia

311

844

3.51

88.33

1.2

1.1

104.98

78.84

u/l

4.20

281

738

Acute renal failure

210

466

4.57

87.07

1.2

1.1

106.97

83.55

u/l

1.87

191

402

Insulin, fast-acting or short human

291

819

3.59

86.82

1.2

1.1

109.79

81.79

u/l

2.93

263

727

Other septicaemia, including avohilmo

314

863

3.45

86.74

1.2

1.1

104.46

78.31

u/l

4.28

284

754

Aplastic and other anaemias

371

1100

3.12

86.37

1.2

1.1

99.68

82.80

u/l

2.50

337

960

Septicaemia

331

913

3.34

86.16

1.2

1.1

104.31

78.12

u/l

4.63

300

797

Disorders of gallbladder, biliary tract and pancreas

642

1654

2.43

84.72

1.2

1.1

93.50

79.01

u/l

3.39

577

1470

Disorders of other endocrine glands

344

1073

3.18

84.66

1.2

1.1

87.97

80.86

u/l

0.59

309

952

Explicit Sepsis

338

969

3.20

82.50

1.2

1.1

103.48

81.22

u/l

3.57

307

856

L04AD Calcineurin inhibitors

136

216

6.45

81.88

1.3

1.1

94.95

80.89

u/l

0.83

129

200

Explicit Sepsis, including avohilmo

341

983

3.17

81.74

1.2

1.1

103.02

81.26

u/l

3.48

310

866

Heart failure, not strict

507

1299

2.64

80.96

1.2

1.1

100.40

78.39

u/l

4.30

459

1158

IBD patients in KELA-register

199

450

4.48

80.56

1.2

71.75

85.00

u/l

1.05

187

402

Disorders of parathyroid gland

219

529

4.16

79.93

1.3

1.1

87.39

79.87

u/l

0.42

200

462

L04AA Selective immunosuppressants

213

516

4.19

78.92

1.2

1.1

83.83

82.29

u/l

0.10

199

460

Bacterial infection, other or unspecified

390

1143

2.90

78.77

1.2

1.1

105.28

78.46

u/l

4.22

359

1003

Implicit Sepsis

500

1432

2.59

78.68

1.2

1.1

94.39

80.55

u/l

1.96

445

1268

Oral corticosteroids

635

1575

2.37

78.67

1.2

1.1

86.56

82.87

u/l

0.45

588

1380

Bacterial Sepsis

351

963

3.04

76.46

1.2

1.1

101.51

81.13

u/l

2.44

319

843

Bacterial infection, other or unspecified, including avohilmo

409

1216

2.78

75.69

1.2

1.1

104.07

78.17

u/l

4.24

374

1070

Noninfective enteritis and colitis

337

1134

2.99

74.96

1.2

1.1

78.42

82.85

u/l

0.35

315

1007

Type 1 diabetes

197

468

4.25

74.64

1.2

1.1

106.35

78.92

u/l

2.03

174

418

Malignant neoplasm of breast, HER2-negative

351

733

3.12

74.23

1.2

1.1

73.17

74.13

u/l

0.09

325

633

Type 1 diabetes, wide definition, subgroup 1

173

373

4.69

74.22

1.2

1.1

112.56

75.35

u/l

2.61

154

338

Malignant neoplasm of breast

351

733

3.12

74.19

1.2

1.1

73.17

74.13

u/l

0.09

325

633

Implicit bacterial Sepsis

318

877

3.14

73.79

1.2

1.1

103.99

81.67

u/l

2.41

286

768

Inflammatory bowel disease, strict (require KELA)

199

482

4.18

73.72

1.2

71.75

84.79

u/l

1.05

187

430

Implicit bacterial Sepsis, including avohilmo

338

936

3.03

73.38

1.2

1.1

101.91

81.47

u/l

2.28

303

821

Hyperparathyroidism

196

467

4.22

73.01

1.3

1.1

83.21

78.97

u/l

0.24

178

410

Persons encountering health services in other circumstances

297

934

3.17

72.91

1.1

85.12

82.54

u/l

0.17

257

817

Malignant neoplasm of breast, HER2-negative, including Hilmo

352

739

3.08

72.83

1.2

1.1

72.68

74.40

u/l

0.19

325

638

Malignant neoplasm of breast, including Hilmo

352

739

3.08

72.81

1.2

1.1

72.68

74.40

u/l

0.19

325

638

Diabetic nephropathy, excluding more controls

173

293

4.91

72.55

1.2

1.1

109.76

86.63

u/l

1.37

163

259

Osteopathies and chondropathies

410

1412

2.67

72.47

1.2

1.1

90.04

82.32

u/l

0.69

371

1254

Nonalcoholic fatty liver disease

130

224

5.95

72.16

1.2

1.1

89.74

73.70

u/l

1.78

115

207

Inflammatory bowel disease

247

707

3.53

72.03

1.2

1.1

73.62

84.61

u/l

1.09

233

631

Malignant neoplasm of breast, HER-positive

293

672

3.29

70.27

1.2

1.1

73.66

74.15

u/l

0.04

276

577

Malignant neoplasm of breast, ER-positive, including Hilmo

293

672

3.28

70.11

1.2

1.1

73.66

74.15

u/l

0.04

276

577

Other and unspecified anaemias

324

1040

2.95

69.24

1.2

1.1

102.61

82.98

u/l

2.72

295

907

Malignant neoplasm

509

1210

2.48

68.98

1.2

1.1

85.21

80.49

u/l

0.56

469

1053

Malignant neoplasm

508

1207

2.48

68.91

1.2

1.1

85.07

80.51

u/l

0.53

468

1050

Other anaemias

326

1050

2.93

68.83

1.2

1.1

102.15

82.95

u/l

2.65

297

915

Type 1 diabetes, wide definition

174

404

4.35

68.03

1.2

1.1

113.20

75.88

u/l

2.65

155

365

Osteoporosis

245

658

3.47

67.74

1.2

1.1

89.96

80.36

u/l

0.69

217

570

Implicit Sepsis, including avohilmo

512

1540

2.39

67.72

1.2

1.1

93.49

80.41

u/l

1.86

454

1372

Reimbursement for rheumatic diseases

398

1536

2.59

67.49

1.2

1.1

85.23

82.85

u/l

0.27

365

1354

Insulin medication

398

1257

2.64

67.43

1.2

1.1

107.40

78.88

u/l

4.66

362

1116

Insulin, intermediate and long-acting

366

1320

2.69

66.56

1.2

1.1

108.65

80.43

u/l

4.03

331

1166

Insulin, combination of fast acting with intermediate-acting or long-acting

398

1398

2.60

66.49

1.2

1.1

107.40

80.19

u/l

4.31

362

1234

Presence of other functional implants

406

1051

2.66

66.37

1.2

1.1

82.54

85.28

u/l

0.28

346

936

Second line medication for Crohn's disease

398

1559

2.57

66.23

1.2

1.1

76.01

83.87

u/l

1.17

375

1378

Malignant neoplasm, wide definition

506

1219

2.43

65.74

1.2

1.1

83.20

80.69

u/l

0.26

468

1062

Persons encountering health services for specific procedures and health care

613

1636

2.22

65.54

1.2

1.1

88.11

79.73

u/l

1.28

557

1452

Diabetic nephropathy

173

407

4.28

65.49

1.2

1.1

109.76

93.17

u/l

0.84

163

360

Malignant neoplasm, including Hilmo

504

1216

2.43

65.37

1.2

1.1

83.25

80.74

u/l

0.26

466

1058

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

452

1625

2.44

65.32

1.2

1.1

94.33

82.43

u/l

1.94

416

1427

Hernia of abdominal wall, postoperative

123

220

5.61

64.74

1.2

1.1

97.79

66.05

u/l

1.98

115

180

Any reimbursement code in KELA

249

329

3.81

64.35

1.2

1.1

73.74

71.45

u/l

0.20

231

293

Diabetic maculopathy, excluding more controls

113

195

5.90

62.58

1.3

1.1

95.21

78.51

u/l

1.12

101

173

Solid cancers

489

1198

2.40

62.42

1.2

1.1

82.38

80.55

u/l

0.17

451

1042

Condition for Implicit Sepsis (Organ dysfunction codes)

511

1550

2.29

61.48

1.2

1.1

92.67

80.12

u/l

1.76

456

1381

Polyarthropathies

427

1100

2.51

60.99

1.2

88.35

84.66

u/l

0.35

389

980

Solid cancers, including Hilmo

490

1212

2.37

60.38

1.2

1.1

81.77

80.39

u/l

0.13

452

1056

5-aminosalicylic acid

166

410

4.09

59.97

1.2

1.1

75.79

81.08

u/l

0.25

153

356

Crohn disease

118

225

5.33

58.67

1.1

1.2

79.76

80.12

u/l

0.01

112

206

ILD medications: azathioprine

128

263

4.94

58.41

1.2

1.1

83.81

85.96

u/l

0.07

123

227

L02BG Aromatase inhibitors

263

887

2.96

57.27

1.2

1.1

72.93

78.91

u/l

0.70

251

773

Sub-endpoint used in defining T1D endpoints

206

598

3.42

57.15

1.2

1.1

110.52

80.76

u/l

2.32

182

541

Medicines for HER+ breast cancer

296

1003

2.78

56.54

1.2

1.1

73.52

80.08

u/l

0.87

279

878

Abnormal results of function studies

104

183

5.81

56.52

1.2

1.1

102.07

76.96

u/l

1.79

165

Ulcerative colitis

184

514

3.62

55.82

1.2

74.85

83.17

u/l

0.52

172

457

L04AX Other immunosuppressants

370

1532

2.43

54.87

1.2

1.1

76.32

82.53

u/l

0.79

348

1356

Complications of surgical and medical care, not elsewhere classified

577

1850

2.09

54.86

1.2

1.1

87.70

82.22

u/l

0.70

528

1635

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

147

355

4.19

54.82

1.2

1.1

66.89

85.06

u/l

2.39

138

322

Cholelithiasis, broad definition with cholecystitis

515

1578

2.18

54.57

1.2

1.1

87.31

79.58

u/l

1.35

462

1398

Ulcerative colitis (strict definition, require KELA)

139

325

4.33

54.10

1.2

1.1

67.11

84.86

u/l

2.16

130

298

Azathioprine

128

283

4.59

53.50

1.2

1.1

83.81

82.89

u/l

0.03

123

248

Any event in cancer register

493

1296

2.23

53.30

1.2

1.1

82.11

81.98

u/l

0.01

449

1135

Budesonide

129

290

4.51

52.82

1.2

1.1

87.04

79.98

u/l

0.39

120

252

Metabolic disorders

539

1523

2.13

52.59

1.2

1.1

91.79

78.55

u/l

2.42

488

1357

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

134

315

4.31

51.81

1.2

1.1

67.09

84.68

u/l

2.04

125

289

Hypertensive diseases (excluding secondary)

295

611

2.82

51.45

1.2

1.1

80.83

71.79

u/l

1.06

273

558

Cholangitis (primary sclerosing, PSC)

116

6.98

51.37

1.2

115.68

79.51

u/l

2.28

104

Diseases of oesophagus, stomach and duodenum

585

1693

2.05

51.28

1.1

87.71

80.79

u/l

1.02

528

1512

Diabetic retinopathy, strict definition

162

387

3.78

50.40

1.2

1.1

110.91

96.91

u/l

0.62

142

351

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

496

1576

2.13

49.93

1.1

93.71

79.61

u/l

2.04

442

1406

Osteoporosis with pathological fracture (FG)

149

6.05

49.83

1.2

1.1

100.62

86.47

u/l

0.37

127

Oxycodone

277

883

2.70

49.48

1.2

1.1

101.96

80.15

u/l

3.01

254

781

Cholelithiasis

484

1557

2.13

48.75

1.2

1.1

82.86

79.36

u/l

0.51

435

1380

Persons encountering health services in other circumstances, wide

602

1543

2.01

48.63

1.2

1.1

83.07

83.33

u/l

0.02

555

1353

Oedema, not elsewhere classified

227

766

2.92

48.27

1.2

1.1

90.50

80.84

u/l

0.73

202

688

Implicit viral Sepsis

157

444

3.57

46.85

1.2

1.1

102.79

81.06

u/l

1.36

147

390

Viral Sepsis

157

444

3.57

46.85

1.2

1.1

102.79

81.06

u/l

1.36

147

390

Other disorders of fluid, electrolyte and acid-base balance

227

749

2.88

46.71

1.2

1.1

96.45

79.91

u/l

1.72

206

652

General symptoms and signs

533

1295

2.07

46.03

1.2

1.1

88.60

79.24

u/l

1.19

470

1166

Heart failure and antihypertensive medication

168

302

3.65

45.31

1.2

1.1

109.86

76.10

u/l

2.66

151

267

Ulcerative colitis, NAS

112

255

4.45

45.18

1.2

72.41

79.67

u/l

0.57

106

233

Hypertension, essential

421

1074

2.23

44.98

1.2

1.1

82.75

76.49

u/l

0.84

376

972

Hypertensive diseases

421

1083

2.20

43.86

1.2

1.1

81.55

76.83

u/l

0.60

379

981

Hypertension

421

1083

2.20

43.84

1.2

1.1

81.55

76.83

u/l

0.60

379

981

Nutritional anaemias

320

1306

2.35

43.81

1.2

1.1

96.93

82.95

u/l

1.24

289

1147

Persons encountering health services for other counselling and medical advice, not elsewhere classified

565

1536

1.96

42.98

1.2

1.1

82.63

83.35

u/l

0.07

534

1347

Disorders of mineral metabolism

175

5.18

42.91

1.3

1.1

105.55

85.23

u/l

0.63

158

Implicit viral Sepsis, including avohilmo

205

717

2.88

42.76

1.2

1.1

96.45

80.76

u/l

1.18

189

632

Heart failure,strict

302

865

2.45

42.29

1.2

1.1

103.19

79.94

u/l

2.54

267

758

Finngen Rheumatological endpoints

477

1324

2.05

41.80

1.2

1.1

88.26

81.35

u/l

0.86

430

1189

Influenza and pneumonia

549

1756

1.93

41.78

1.2

1.1

89.77

79.59

u/l

2.25

501

1553

Insulin, fast-acting (human)

103

234

4.45

41.68

1.3

1.1

120.53

73.87

u/l

2.05

213

Acute tubulo-interstitial nephritis

354

1350

2.22

41.63

1.2

1.1

89.24

78.09

u/l

1.95

320

1181

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

510

1527

1.99

41.52

1.1

94.51

77.52

u/l

3.07

454

1366

Gastro-oesophageal reflux disease

396

1581

2.12

41.45

1.1

86.66

81.10

u/l

0.54

361

1407

Other disorders of skin and subcutaneous tissue

433

1799

2.04

40.86

1.2

1.1

94.27

80.93

u/l

1.87

394

1592

All pneumoniae

534

1806

1.93

40.65

1.2

1.1

90.87

79.86

u/l

2.46

487

1601

Pneumonias (Asthma/COPD co-morbidities)

529

1802

1.92

40.10

1.2

1.1

89.61

80.18

u/l

1.97

483

1598

Other heart diseases

249

615

2.64

39.98

1.2

1.1

91.93

71.48

u/l

2.12

232

558

Primary hyperparathyroidism

115

294

3.98

39.94

1.2

86.25

77.91

u/l

0.32

104

262

Gout

180

514

3.03

39.76

1.1

101.39

91.18

u/l

0.51

159

448

Diabetes mellitus

530

1587

1.93

39.73

1.1

1.2

93.42

77.08

u/l

3.14

472

1421

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

157

5.26

39.72

1.1

1.2

93.15

77.33

u/l

1.52

136

General examination and investigation of persons without complaint and reported diagnosis

328

720

2.37

39.66

1.2

1.1

82.12

82.03

u/l

0.01

312

618

Iron deficiency anaemia

274

1132

2.39

39.23

1.2

1.1

97.50

82.69

u/l

1.12

250

999

Infections, IBD-co-morbidities

104

159

4.64

39.22

1.1

105.71

77.37

u/l

1.56

146

Pneumonia, organism unspecified

485

1706

1.96

39.04

1.2

1.1

90.75

79.84

u/l

2.36

440

1509

Caries of dentine

152

454

3.26

39.00

1.3

1.1

95.66

89.21

u/l

0.28

143

408

Complications of medical and surgical care

425

1909

2.01

38.92

1.2

1.1

90.95

81.88

u/l

0.98

397

1681

Hypothyroidism, levothyroxine purchases

108

126

4.83

38.79

1.2

104.81

65.80

u/l

1.53

117

Hypothyroidism and >3 levothyroxin purchases

108

126

4.83

38.79

1.2

104.81

65.80

u/l

1.53

117

Hypothyroidism (congenital or acquired)

108

126

4.82

38.73

1.2

105.97

65.80

u/l

1.58

117

Diabetes, varying definitions

524

1590

1.92

38.29

1.2

93.71

77.01

u/l

3.23

468

1423

Hypothyroidism, drug reimbursement

100

5.70

37.89

1.2

97.33

67.53

u/l

1.05

Other noninfective gastroenteritis and colitis

166

559

2.99

37.28

1.2

79.17

83.95

u/l

0.24

155

489

Nausea and vomiting

177

601

2.89

37.24

1.2

1.1

102.62

80.49

u/l

1.36

163

534

Mucosal proctocolitis

214

4.40

37.08

1.2

1.1

71.61

82.11

u/l

0.79

198

Ulcer of lower limb, not elsewhere classified

118

324

3.69

36.95

1.2

1.1

128.09

84.54

u/l

1.96

105

289

Other medical care

293

1081

2.29

36.85

1.2

1.1

92.53

83.01

u/l

0.83

267

951

Disorders of thyroid, IBD co-morbidities

108

174

4.28

36.75

1.2

1.1

78.47

75.02

u/l

0.17

100

157

Other diseases of blood and blood-forming organs, wide

161

539

3.02

36.64

1.2

1.1

97.49

84.36

u/l

1.07

147

474

Type 2 diabetes, wide definition

440

1399

1.99

36.57

1.1

103.00

77.85

u/l

4.51

397

1249

Certain infectious and parasitic diseases

468

1186

1.98

36.29

1.2

1.1

87.33

77.83

u/l

1.23

419

1058

Dental caries

160

503

3.02

36.15

1.2

94.64

88.45

u/l

0.28

150

452

Diabetes, insulin treatment (Kela reimbursement)

531

1698

1.87

36.12

1.1

94.50

78.98

u/l

2.82

474

1517

Other retinal disorders

376

1390

2.06

35.94

1.2

1.1

101.09

83.28

u/l

2.16

330

1229

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

117

329

3.60

35.40

1.1

123.22

84.53

u/l

3.15

103

292

Hypothyroidism, strict autoimmune

344

1055

2.15

35.27

1.2

1.1

85.58

81.28

u/l

0.33

297

928

Disorders of calcium metabolism

133

5.37

35.15

1.2

1.1

112.82

73.98

u/l

1.20

120

Gout, FINNGEN

180

651

2.77

35.04

1.1

101.39

90.29

u/l

0.58

159

569

Type 2 diabetes

505

1558

1.88

35.02

1.1

89.96

77.26

u/l

2.29

453

1395

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

508

1828

1.86

34.84

1.2

1.1

89.51

80.51

u/l

1.88

463

1619

Ulcerative colitis (strict definition, all Crohn cases excluded)

102

265

3.89

34.59

1.2

1.1

65.99

80.32

u/l

1.66

241

Diseases of arteries, arterioles and capillaries (FINNGEN)

151

327

3.21

34.58

1.2

1.1

126.19

70.47

u/l

3.68

138

296

Heart failure, strict

329

1067

2.15

34.39

1.1

104.54

82.45

u/l

2.61

289

939

Diabetic maculopathy

110

283

3.73

34.37

1.3

1.1

95.29

99.16

u/l

0.14

257

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

464

1419

1.92

34.10

1.2

1.1

88.03

81.32

u/l

1.01

421

1253

464

1419

1.92

34.10

1.2

1.1

88.03

81.32

u/l

1.01

421

1253

Complications of procedures, not elsewhere classified

430

1816

1.91

33.69

1.2

1.1

85.19

82.44

u/l

0.29

391

1603

Other heart diseases, wide

454

1439

1.92

33.54

1.2

92.28

77.51

u/l

2.22

409

1297

All-cause Heart Failure

323

1052

2.15

33.50

1.1

104.63

82.45

u/l

2.56

284

924

Erysipelas, including avohilmo

380

1413

2.00

33.24

1.1

91.69

79.07

u/l

2.21

340

1249

Cirrhosis of liver, NAS

112

5.67

32.92

1.1

135.54

73.42

u/l

4.27

100

Diabetes medication

526

1694

1.82

32.92

1.1

94.27

77.53

u/l

3.20

468

1515

Other soft tissue disorders, not elsewhere classified

460

1383

1.90

32.60

1.2

1.1

81.26

84.16

u/l

0.30

418

1229

Abnormalities of breathing

433

1284

1.93

32.54

1.1

1.2

83.78

80.79

u/l

0.36

385

1158

Disorders of choroid and retina

447

1669

1.88

32.36

1.2

1.1

97.98

81.40

u/l

2.37

394

1484

Unspecified kidney failure

187

4.39

32.23

1.1

93.57

83.39

u/l

0.40

163

Constipation

481

1779

1.84

32.16

1.2

1.1

82.24

84.30

u/l

0.20

420

1589

Other and unspecified iron deficiency

214

885

2.43

32.03

1.2

1.1

97.14

81.74

u/l

0.90

194

782

Non-invasive ventilation

140

396

3.07

31.88

1.1

1.2

99.69

72.88

u/l

2.85

129

358

Erysipelas

295

1196

2.14

31.71

1.1

93.92

77.81

u/l

3.01

263

1052

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

345

1705

1.99

31.50

1.1

92.09

82.16

u/l

0.94

326

1496

Other inflammatory liver diseases

118

5.35

31.08

1.1

103.65

70.85

u/l

2.36

108

Pain in limb

411

1366

1.92

30.90

1.2

1.1

78.43

84.35

u/l

0.73

369

1212

Other disorders of skin and subcutaneous tissue, not elsewhere classified

111

330

3.40

30.88

1.2

1.1

100.89

80.52

u/l

1.37

103

290

Endocrine, nutritional and metabolic diseases

327

783

2.11

30.21

1.2

1.1

78.79

74.40

u/l

0.43

294

707

Cardiovascular diseases (excluding rheumatic etc)

271

691

2.25

30.13

1.2

75.36

70.49

u/l

0.67

252

628

Other diseases of intestines

505

1570

1.80

30.11

1.2

1.1

86.71

82.70

u/l

0.41

451

1407

Diarrhoea and gastroenteritis of presumed infectious origin

362

1673

1.94

30.10

1.2

1.1

89.94

80.39

u/l

1.17

321

1494

Malaise and fatigue

272

990

2.17

29.99

1.1

91.92

82.12

u/l

0.99

238

888

Postmenopausal osteoporosis with pathological fracture

161

4.57

29.95

1.2

1.1

106.55

67.88

u/l

1.24

142

Liquid cancers, including Hilmo

198

713

2.46

29.82

1.1

105.55

81.71

u/l

3.34

180

613

Diabetic retinopathy, excluding more controls

185

385

2.71

29.82

1.2

1.1

109.84

84.35

u/l

1.89

166

341

Other disorders of kidney and ureter

101

292

3.50

29.38

1.2

1.1

83.82

86.37

u/l

0.12

266

Noninfectious colitis NAS

269

3.61

29.25

1.2

85.11

81.75

u/l

0.09

242

Dyspnoea

464

1881

1.79

28.71

1.1

89.59

82.27

u/l

1.16

414

1676

Tramadol

388

1229

1.90

28.26

1.2

1.1

93.81

77.45

u/l

2.46

345

1098

Diseases of the digestive system

255

1199

2.12

27.73

1.2

1.1

93.63

84.00

u/l

0.69

229

1058

Gastrointestinal diseases

234

500

2.35

27.69

1.1

1.2

75.96

71.86

u/l

0.42

214

439

Disorders of lens

360

1160

1.93

27.57

1.2

1.1

95.64

81.13

u/l

1.63

328

1029

Vocal cord dysfunction

180

3.99

27.57

1.1

87.73

73.23

u/l

0.42

160

Bleeding

427

1661

1.81

27.41

1.2

1.1

90.77

83.03

u/l

0.98

390

1467

Liquid cancers

163

610

2.54

26.76

1.1

108.30

83.04

u/l

3.46

148

522

Intestinal infectious diseases

465

1989

1.74

26.69

1.2

1.1

94.95

80.45

u/l

2.10

415

1773

Acute peritonitis

124

4.84

26.45

1.2

71.96

86.08

u/l

0.91

114

Other diseases of biliary tract

174

4.14

26.22

1.3

1.2

104.55

76.05

u/l

2.10

156

Sleep apnoea

480

1751

1.73

26.14

1.1

80.41

85.55

u/l

0.82

422

1568

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

317

1659

1.91

25.95

1.2

1.1

90.44

82.93

u/l

0.59

299

1462

Gout, strict definition

116

394

2.97

25.89

1.1

97.71

90.45

u/l

0.35

103

350

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

109

4.54

25.86

1.2

1.1

88.06

81.96

u/l

0.23

Dermatitis and eczema

541

1916

1.68

25.77

1.2

1.1

83.00

83.31

u/l

0.03

487

1705

Diseases of the skin and subcutaneous tissue

443

1245

1.79

25.56

1.2

1.1

84.06

82.19

u/l

0.16

399

1101

Systemic connective tissue disorders

209

950

2.21

25.38

1.1

86.83

81.62

u/l

0.49

192

839

Amputation

211

3.74

25.10

1.2

1.1

141.03

84.32

u/l

1.63

184

Dermatitis

334

1763

1.86

24.97

1.2

1.1

86.31

82.72

u/l

0.32

302

1566

Neoplasms

296

768

2.03

24.94

1.2

1.1

82.44

78.58

u/l

0.29

266

672

Autoimmune hepatitis, wide definition

5.98

24.83

1.1

100.38

87.45

u/l

0.49

Gout, unspecified

124

449

2.78

24.63

1.1

100.86

92.45

u/l

0.29

109

395

Benzodiazepine use

489

1962

1.69

24.54

1.2

1.1

81.47

83.76

u/l

0.23

436

1748

Diabetic retinopathy

222

625

2.22

24.45

1.2

1.1

103.44

92.88

u/l

0.62

195

556

Biological medication for rheuma

113

391

2.91

24.42

1.2

1.1

71.97

78.68

u/l

0.46

108

353

Hypothyroidism, other/unspecified

428

1617

1.74

24.15

1.2

1.1

86.82

82.30

u/l

0.39

376

1448

Hypo-osmolality and hyponatraemia

117

412

2.84

24.09

1.2

1.1

93.34

83.29

u/l

0.40

104

362

Gout, idiopatic and unspecified

146

582

2.53

23.95

1.1

100.75

89.88

u/l

0.49

128

509

Medical observation and evaluation for suspected diseases and conditions

285

720

2.03

23.92

1.2

1.1

88.93

82.03

u/l

0.55

261

618

Peripheral artery operations in Hilmo

266

3.34

23.92

1.2

1.1

139.96

86.08

u/l

1.78

236

Disorders of the thyroid gland

449

1704

1.71

23.72

1.2

1.1

86.43

82.91

u/l

0.29

403

1527

Cardiac arrhythmias

273

873

2.01

23.71

1.2

84.65

72.74

u/l

1.41

241

785

Other and unspecified dermatitis

284

1488

1.92

23.43

1.2

1.1

84.14

81.77

u/l

0.22

261

1321

Symptoms and signs involving the digestive system and abdomen

444

1284

1.74

23.23

1.2

1.1

85.29

81.93

u/l

0.31

395

1143

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

140

537

2.54

23.17

1.2

1.1

105.71

81.98

u/l

1.23

128

458

Intestinal infectious diseases, including avohilmo, including avohilmo

546

1871

1.63

23.10

1.2

1.1

87.42

81.17

u/l

0.75

485

1669

Other functional intestinal disorders

247

1120

2.01

23.07

1.2

1.1

78.46

84.53

u/l

0.49

223

996

Agranulocytosis

258

3.34

23.02

1.3

1.2

91.04

77.06

u/l

0.87

231

Atrial fibrillation and flutter

164

433

2.46

22.96

1.2

1.1

93.58

71.35

u/l

1.88

148

395

Abnormal findings on diagnostic imaging of lung

258

1245

1.97

22.93

1.2

1.1

95.25

82.23

u/l

1.43

241

1089

Other cataract

240

871

2.06

22.90

1.2

1.1

95.53

83.50

u/l

0.90

219

763

Sleep apnoea, including avohilmo

484

1767

1.66

22.47

1.1

77.97

85.65

u/l

1.53

427

1580

Vitreous haemorrhage

225

3.46

22.15

1.3

1.1

97.42

86.68

u/l

0.45

201

Seropositive rheumatoid arthritis

141

571

2.47

22.11

1.2

1.1

77.75

83.73

u/l

0.56

129

507

Obesity due to excess calories

248

1267

1.97

22.10

1.1

1.2

79.38

81.14

u/l

0.18

224

1143

Cholecystectomy

369

1798

1.75

22.06

1.2

1.1

82.64

84.56

u/l

0.20

335

1592

Opioids

427

1282

1.72

21.97

1.2

1.1

85.99

77.09

u/l

1.19

381

1147

Sulfasalazine

152

648

2.36

21.57

1.2

1.1

75.11

82.56

u/l

0.77

135

568

Symptoms and signs involving the urinary system

378

1648

1.73

21.56

1.1

90.07

83.48

u/l

0.68

335

1462

Diseases of peritoneum

235

3.36

21.41

1.2

70.25

79.89

u/l

0.82

212

Infections of the skin and subcutaneous tissue

284

1512

1.85

21.19

1.2

1.1

93.77

81.55

u/l

1.02

256

1353

Hypothyreosis and Thyroxine purchase for inclusion criteria

439

1729

1.67

21.09

1.2

1.1

86.23

82.11

u/l

0.35

386

1549

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

131

242

2.72

20.84

1.2

1.1

80.51

67.66

u/l

1.18

121

218

Cerebrovascular diseases (FINNGEN)

156

463

2.37

20.78

1.2

1.1

102.34

70.15

u/l

2.56

142

424

Other systemic involvement of connective tissue (FG)

140

574

2.41

20.74

1.1

85.31

83.99

u/l

0.07

123

509

Heart failure and coronary heart disease

224

772

2.04

20.72

1.2

1.1

110.83

82.63

u/l

2.50

195

669

Pain in throat and chest

373

1269

1.74

20.68

1.1

83.33

80.91

u/l

0.19

334

1145

Exposure to unspecified factor

476

2007

1.62

20.45

1.2

1.1

92.04

81.07

u/l

1.42

414

1802

Abnormal findings on diagnostic imaging of other body structures

347

2.85

20.41

1.1

97.61

77.05

u/l

1.13

305

Complications of internal orthopaedic prosthetic devices, implants and grafts

141

597

2.38

20.38

1.3

1.1

89.07

84.81

u/l

0.18

130

515

Other disorders of urethra and urinary system

356

1425

1.74

20.37

1.2

1.1

79.23

84.51

u/l

0.73

320

1280

Chronic pancreatitis

248

3.22

20.29

1.2

1.1

112.16

85.96

u/l

1.07

221

Other arthritis (FG)

159

710

2.25

20.28

1.2

1.1

93.99

82.53

u/l

0.69

144

639

Other special examinations and investigations of persons without complaint or reported diagnosis

274

720

1.93

20.19

1.1

85.88

82.03

u/l

0.26

248

618

Hard cardiovascular diseases

406

1430

1.68

19.78

1.1

94.17

78.16

u/l

2.28

368

1285

Cardiovascular diseases

224

582

2.05

19.60

1.2

74.36

69.61

u/l

0.55

205

530

Rheumatoid arthritis

179

748

2.13

19.46

1.1

77.54

85.21

u/l

0.97

163

663

Other diseases of the digestive system

169

792

2.14

19.15

1.2

1.1

93.16

88.27

u/l

0.23

153

693

Depression medications

132

3.32

19.12

1.1

1.2

77.35

65.33

u/l

0.96

122

Implicit fungal Sepsis, including avohilmo

142

3.92

19.02

1.1

85.60

79.81

u/l

0.19

129

Other diseases of pancreas

184

3.52

18.94

1.1

1.2

121.91

77.59

u/l

1.68

164

Senile cataract

310

1056

1.79

18.93

1.2

1.1

92.13

81.86

u/l

0.93

281

930

Hyperlipidaemia, other/unspecified

200

895

2.02

18.91

1.2

1.1

88.81

79.89

u/l

0.62

174

787

Abdominal and pelvic pain

423

1284

1.66

18.85

1.2

1.1

84.43

81.93

u/l

0.21

371

1143

Other nutritional deficiencies

326

1734

1.72

18.81

1.1

78.87

83.02

u/l

0.60

293

1548

Parasetamol

276

744

1.88

18.79

1.2

86.78

80.69

u/l

0.44

248

673

Atrial fibrillation and flutter with reimbursement

133

342

2.46

18.72

1.2

1.1

86.52

70.82

u/l

2.26

119

308

Codeine

394

1272

1.68

18.69

1.1

80.66

76.91

u/l

0.39

350

1137

Missing teeth due to accident, extraction or parodontitis

320

1661

1.73

18.56

1.2

1.1

82.95

84.79

u/l

0.13

274

1485

Exclusions for E4_PCOS_BROAD

366

2.69

18.43

1.2

1.1

93.07

85.13

u/l

0.24

331

Enlarged lymph nodes

312

2.84

18.30

1.1

91.82

78.13

u/l

0.99

285

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

192

585

2.08

18.22

1.2

1.1

84.11

71.85

u/l

1.74

177

535

Ischemic heart diseases

403

1461

1.65

18.20

1.1

91.41

80.03

u/l

1.41

367

1305

Percutaneous Coronary Intervention

386

1418

1.66

18.07

1.1

95.01

80.34

u/l

1.84

350

1266

Other disorders of adrenal gland

4.84

18.03

1.1

1.2

82.60

81.72

u/l

0.02

Antihypertensive medication - note that there are other indications

220

577

2.00

17.99

1.2

74.18

72.89

u/l

0.11

202

517

Other diseases of pleura

228

1049

1.90

17.94

1.1

103.45

83.07

u/l

2.72

202

915

COPD/asthma related infections

452

1419

1.60

17.52

1.2

1.1

82.03

81.32

u/l

0.07

412

1253

COPD/asthma/ILD related infections

452

1419

1.60

17.52

1.2

1.1

82.03

81.32

u/l

0.07

412

1253

Disorders of lipoprotein metabolism and other lipidaemias

382

1412

1.65

17.46

1.2

1.1

92.88

79.09

u/l

1.96

339

1262

Asthma, excluding more controls

306

889

1.77

17.39

1.1

78.40

75.57

u/l

0.31

283

787

Asthma, unspecified (mode), excluding more controls

228

862

1.90

17.38

1.1

77.47

76.01

u/l

0.14

208

762

Valvular heart disease excluding rheumatic fever

223

836

1.91

17.35

1.1

100.58

78.96

u/l

2.24

200

744

Certain infectious and parasitic diseases, including avohilmo

306

867

1.77

17.33

1.2

1.1

83.88

82.06

u/l

0.11

278

774

Hydronephrosis

215

3.19

17.32

1.1

100.50

79.08

u/l

0.74

190

Enterocolitis due to Clostridium difficile

231

3.10

17.25

1.1

105.54

82.41

u/l

1.15

206

Non-rheumatic valve diseases

222

833

1.91

17.19

1.1

99.47

79.00

u/l

2.07

199

741

Emergency coronary revascularization (for ACS)

408

1531

1.61

17.08

1.1

94.43

81.32

u/l

1.63

370

1363

Iron deficiency anaemia secondary to blood loss (chronic)

365

2.62

16.97

1.2

1.1

93.93

83.37

u/l

0.57

325

All influenza

130

576

2.27

16.97

1.2

1.1

90.58

82.30

u/l

0.59

121

501

Syncope and collapse

205

890

1.93

16.92

1.1

87.97

81.04

u/l

0.38

183

798

Major coronary heart disease event

402

1497

1.61

16.71

1.1

94.64

80.35

u/l

1.87

364

1333

Symptoms and signs involving the circulatory and respiratory systems

413

1284

1.61

16.71

1.1

1.2

83.17

80.79

u/l

0.23

369

1158

Obesity and other hyperalimentation

304

1691

1.69

16.70

1.1

1.2

80.33

82.28

u/l

0.23

276

1511

Obesity

302

1683

1.69

16.58

1.1

1.2

80.25

82.29

u/l

0.24

275

1503

Symptoms and signs concerning food and fluid intake

195

3.25

16.56

1.0

1.1

82.61

80.36

u/l

0.10

179

Excluding asthma or asthma-COPD overlap

333

981

1.70

16.52

1.2

1.1

79.62

79.54

u/l

0.01

305

861

Coronary revascularization (ANGIO or CABG)

379

1419

1.63

16.46

1.1

95.41

80.32

u/l

1.87

343

1267

Volume depletion

187

3.29

16.36

1.3

1.1

99.00

87.57

u/l

0.36

168

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

457

1896

1.55

16.35

1.2

1.1

86.35

80.78

u/l

0.70

406

1690

Hypercalcemia

100

4.28

16.27

1.2

121.70

78.88

u/l

0.73

Other diseases of anus and rectum

161

787

2.05

16.24

1.1

78.48

84.92

u/l

0.66

134

701

Pain in joint

256

873

1.81

16.23

1.2

1.1

73.61

83.93

u/l

2.01

235

782

Other specified/unspecified arthritis

143

672

2.14

16.19

1.1

94.61

84.88

u/l

0.49

129

598

Family history of malignant neoplasm

240

2.98

16.17

1.1

70.18

75.76

u/l

0.46

220

GI-bleeding

160

785

2.05

16.15

1.2

1.1

95.19

88.62

u/l

0.32

144

689

Other symptoms and signs involving the digestive system and abdomen

398

2.50

16.13

1.1

1.2

82.34

78.05

u/l

0.22

359

Other pulmonary diagnosis

331

981

1.69

16.09

1.2

1.1

79.49

79.54

u/l

0.00

303

861

Drug-induced neutropenia

170

3.40

16.02

1.2

95.60

76.95

u/l

0.84

155

Diseases of the ear and mastoid process

493

1617

1.53

15.91

1.2

1.1

85.54

81.78

u/l

0.44

455

1433

Intestinal stricture

166

832

2.01

15.82

1.2

1.1

100.55

84.25

u/l

0.98

156

730

Thyrotoxicosis, other and/or unspecified

117

512

2.30

15.80

1.2

1.1

72.62

79.56

u/l

0.69

109

457

Cellulitis

117

512

2.30

15.79

1.2

1.1

102.26

79.93

u/l

1.24

107

454

Asthma

319

971

1.70

15.75

1.1

79.49

79.81

u/l

0.03

295

852

Injuries to the hip and thigh

239

1203

1.79

15.75

1.2

1.1

97.63

83.21

u/l

0.94

208

1064

Other bacterial intestinal infections

403

2.47

15.72

1.1

97.61

81.64

u/l

0.84

358

Fracture of lumbar spine and pelvis

126

569

2.22

15.68

1.1

83.70

85.12

u/l

0.08

115

499

Diseases of arteries, arterioles and capillaries

315

1389

1.67

15.67

1.2

1.1

110.67

80.43

u/l

3.61

288

1225

STROKE

265

1021

1.75

15.51

1.1

96.27

75.63

u/l

2.43

241

915

Spondyloarthritis

330

2.62

15.43

1.2

1.1

83.83

86.77

u/l

0.11

294

Other and unspecified polyneuropathies, also in other diseases

107

456

2.36

15.38

1.2

1.1

116.05

84.78

u/l

1.12

403

514

1738

1.50

15.26

1.2

1.1

82.98

82.31

u/l

0.07

463

1540

Cough

199

998

1.87

15.23

1.2

1.1

74.90

82.96

u/l

1.00

176

894

COPD differential diagnosis

327

982

1.67

15.19

1.2

1.1

79.21

79.86

u/l

0.06

299

862

ILD differential diagnosis

327

982

1.67

15.18

1.2

1.1

79.21

79.86

u/l

0.06

299

862

Chronic apical periodontitis

488

1816

1.51

15.17

1.2

1.1

80.61

83.46

u/l

0.31

430

1628

Type 2 diabetes, definitions combined, including avohilmo

412

1525

1.56

15.17

1.1

87.48

78.97

u/l

1.23

374

1365

Fall on same level

492

1740

1.51

15.16

1.2

1.1

89.95

80.18

u/l

1.42

432

1564

Presence of cardiac and vascular implants and grafts

188

720

1.93

15.15

1.2

1.1

106.85

87.35

u/l

1.51

172

631

Fracture of femur

146

636

2.08

15.10

1.2

1.1

102.71

83.62

u/l

0.83

122

555

ILD, hospital admission 2, with pulmonary infections

203

3.08

14.96

1.2

1.1

89.79

89.05

u/l

0.02

181

Asthma, unspecified (mode)

233

942

1.79

14.89

1.1

77.94

80.31

u/l

0.22

213

825

Unspecified urinary incontinence

225

2.97

14.87

1.1

77.52

75.66

u/l

0.09

204

Hypothyroidism, strict autoimmune, 3 medication purchases required

380

1625

1.57

14.81

1.2

1.1

84.65

81.77

u/l

0.23

327

1457

Pain, not elsewhere classified

134

639

2.11

14.65

1.1

79.46

78.66

u/l

0.05

120

578

Heart failure and bmi 25plus

180

620

1.94

14.59

1.1

100.87

79.45

u/l

1.59

161

550

Non-ischemic cardiomyopathy

160

639

2.00

14.47

1.1

92.90

79.61

u/l

1.14

138

558

Sequelae with surgical and medical care as external cause

115

520

2.23

14.42

1.2

1.1

84.21

84.00

u/l

0.01

108

457

Follow-up examination after treatment for conditions other than malignant neoplasms

187

654

1.91

14.41

1.2

1.1

74.25

81.57

u/l

1.04

170

561

Bacterial intestinal infections, IBD co-morbidities

101

433

2.35

14.35

1.1

104.88

80.35

u/l

1.20

383

Other bacterial intestinal infections, including avohilmo

121

560

2.17

14.31

1.1

91.88

80.33

u/l

0.68

107

492

Polyneuropathies and other disorders of the peripheral nervous system

116

528

2.21

14.31

1.2

1.1

114.05

82.46

u/l

1.28

107

470

Other (not insulin) diabetes medications

429

1651

1.53

14.28

1.1

87.74

78.06

u/l

1.66

382

1476

Asthma (mode)

310

982

1.66

14.27

1.1

80.43

79.86

u/l

0.05

284

862

Type 2 diabetes, strict (exclude DM1)

410

1549

1.54

14.25

1.1

88.99

78.75

u/l

1.62

371

1386

Cutaneous abscess, furuncle and carbuncle

125

587

2.14

14.24

1.2

1.1

93.99

81.73

u/l

0.57

114

524

Dipeptidyl peptidase 4 (DPP-4) inhibitors

268

1248

1.69

14.21

1.1

1.2

90.06

83.61

u/l

0.52

239

1105

Type 2 diabetes, definitions combined

406

1532

1.54

14.19

1.1

89.20

77.44

u/l

2.02

367

1371

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.38

14.06

1.2

1.1

101.53

88.55

u/l

0.38

Hypertensive heart and/or renal disease

126

427

2.16

13.90

1.2

1.1

96.48

78.61

u/l

1.24

113

374

Intracranial trauma

241

937

1.74

13.90

1.2

1.1

82.81

80.84

u/l

0.11

205

845

Asthma (only as main-diagnosis), excluding more controls

273

889

1.70

13.89

1.1

80.06

75.57

u/l

0.46

251

787

Other diseases of urinary system

429

1588

1.52

13.81

1.2

1.1

83.02

84.95

u/l

0.20

381

1425

Thyrotoxicosis with diffuse goitre

332

2.52

13.75

1.2

68.95

77.05

u/l

0.85

298

Rheumatoid arthritis, including avohilmo

194

1074

1.81

13.75

1.1

79.54

82.74

u/l

0.32

176

951

Sleep disorders (combined)

475

1668

1.49

13.74

1.1

81.60

84.64

u/l

0.35

420

1492

Recurrent or chronic depression

185

685

1.88

13.74

1.2

85.43

79.82

u/l

0.34

164

627

Other systemic involvement of connective tissue

143

717

2.00

13.70

1.1

86.50

80.76

u/l

0.41

126

631

Nerve, nerve root and plexus disorders

471

1911

1.48

13.69

1.2

1.1

84.26

83.16

u/l

0.10

434

1694

Peripheral artery disease

210

933

1.78

13.55

1.2

1.1

112.53

83.77

u/l

2.32

192

810

Low back pain

345

1483

1.57

13.48

1.2

1.1

74.81

85.02

u/l

2.34

301

1322

Elevated blood glucose level

149

3.32

13.39

1.2

1.1

113.79

76.21

u/l

2.07

130

Familial hypercholesterolemia, with ischemic heart disease

190

3.03

13.38

1.2

1.1

128.60

84.88

u/l

1.19

167

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

173

935

1.86

13.27

1.2

1.1

83.91

81.03

u/l

0.14

157

834

Psoriatic and enteropathic arthropathies

229

2.82

13.23

1.1

79.26

85.40

u/l

0.20

203

Sequelae of external causes of morbidity and mortality

135

672

2.02

13.22

1.2

1.1

91.54

84.57

u/l

0.35

127

589

Paralytic ileus and intestinal obstruction

132

651

2.04

13.22

1.3

1.1

102.55

85.70

u/l

0.76

122

575

Other specific joint derangements/joint disorders

297

1139

1.63

13.17

1.2

77.61

82.98

u/l

0.71

275

1019

AV-block

316

2.42

13.14

1.1

97.37

83.49

u/l

0.97

279

Gastroduodenal ulcer

124

600

2.07

13.00

1.1

102.51

88.27

u/l

0.92

109

526

Thyrotoxicosis

137

690

2.00

12.99

1.1

71.78

81.90

u/l

1.25

126

612

Chronic laryngitis and laryngotracheitis

336

2.46

12.94

1.2

91.00

80.75

u/l

0.31

304

Other respiratory diseases principally affecting the interstitium

441

2.26

12.92

1.2

1.1

88.08

84.29

u/l

0.18

390

Coagulation defects, purpura and other haemorrhagic conditions

102

460

2.23

12.92

1.3

1.1

96.13

82.60

u/l

0.88

412

Continuous positive airway pressure

275

2.50

12.90

1.1

1.2

83.65

75.78

u/l

0.60

246

Papulosquamous disorders

193

1090

1.78

12.83

1.2

1.1

80.82

83.52

u/l

0.17

171

974

Other disorders of ear

411

1777

1.50

12.75

1.2

1.1

85.44

84.05

u/l

0.11

378

1571

Psoriasis

144

743

1.95

12.74

1.2

1.1

79.44

83.52

u/l

0.22

127

666

Vitamin B12 deficiency anaemia

212

2.85

12.71

1.2

1.1

84.44

83.54

u/l

0.03

189

Persons encountering health services for examination and investigation

246

720

1.72

12.70

1.1

84.42

82.03

u/l

0.14

226

618

Fitting and adjustment of other devices

174

836

1.84

12.69

1.2

1.1

91.51

85.16

u/l

0.33

160

730

Other/unspecified seropositive rheumatoid arthritis

141

724

1.96

12.67

1.2

1.1

77.75

81.49

u/l

0.35

129

642

Hypokalaemia

269

2.62

12.63

1.1

99.38

81.86

u/l

0.94

239

Other symptoms and signs involving the nervous and musculoskeletal systems

200

1147

1.75

12.60

1.2

1.1

82.70

81.83

u/l

0.04

182

1021

Certain disorders involving the immune mechanism

446

2.23

12.59

1.2

1.1

95.30

81.57

u/l

0.85

401

Other arrhythmias

279

1290

1.62

12.53

1.1

78.53

77.48

u/l

0.11

248

1160

Faecal incontinence

209

2.85

12.46

1.1

1.2

64.48

75.80

u/l

1.37

186

Supplementary factors related to causes of morbidity and mortality classified elsewhere

149

784

1.91

12.45

1.2

1.1

96.42

82.75

u/l

0.59

129

698

Leisure time condition

404

2.29

12.43

1.1

89.14

81.82

u/l

0.25

363

Seropositive rheumatoid arthritis, wide

141

729

1.94

12.43

1.2

1.1

77.75

81.50

u/l

0.35

129

647

Codeine or tramadol medication

478

1789

1.45

12.38

1.2

1.1

80.15

83.97

u/l

0.45

416

1601

Diseases of external ear

169

929

1.83

12.31

1.1

89.67

83.23

u/l

0.34

155

823

Other CVD (FINNGEN)

163

2.87

12.29

1.1

94.57

72.41

u/l

0.56

145

Covid-19 confirmed case

177

987

1.80

12.24

1.2

1.1

97.28

83.65

u/l

1.10

165

864

Asthma (only as main-diagnosis)

282

971

1.63

12.22

1.1

80.73

79.81

u/l

0.07

259

852

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

138

713

1.95

12.20

1.2

1.1

77.09

81.26

u/l

0.39

126

631

Myocardial infarction

218

890

1.72

12.11

1.1

113.28

80.71

u/l

2.50

194

777

Diseases of the respiratory system

272

829

1.65

12.10

1.1

78.55

82.77

u/l

0.40

246

732

Presence of other devices

118

569

2.05

12.07

1.2

1.1

82.02

84.61

u/l

0.13

108

496

Mycoses

137

710

1.94

12.00

1.1

94.78

83.65

u/l

0.64

121

629

Gonarthrosis [arthrosis of knee](FG)

314

1153

1.57

11.86

1.1

82.37

83.95

u/l

0.11

274

1034

Pure hypercholesterolaemia

328

1349

1.55

11.85

1.2

1.1

94.71

79.26

u/l

1.98

293

1203

Episodal and paroxysmal disorders

445

1544

1.46

11.83

1.1

83.88

83.61

u/l

0.02

399

1379

Irritable bowel syndrome

133

687

1.94

11.77

1.1

72.97

80.49

u/l

0.72

117

617

Primary_lymphoid and hematopoietic malignant neoplasms

121

606

2.01

11.71

1.1

108.98

85.38

u/l

2.29

109

531

Familial hypercholesterolemia

322

2.41

11.66

1.2

1.1

124.22

82.68

u/l

1.43

284

Other antidepressants

427

1487

1.47

11.54

1.2

1.1

81.97

85.60

u/l

0.40

382

1332

Statin medication

280

985

1.60

11.52

1.2

1.1

77.04

80.99

u/l

0.49

253

899

Other diseases of pericardium

4.00

11.48

1.1

78.78

79.40

u/l

0.01

Mood disorders, excluding more controls

402

1604

1.48

11.47

1.2

1.1

82.12

80.91

u/l

0.10

348

1437

Injuries to the abdomen, lower back, lumbar spine and pelvis

183

1038

1.74

11.42

1.1

83.24

84.03

u/l

0.05

165

915

Coxarthrosis [arthrosis of hip](FG)

236

985

1.65

11.40

1.1

80.43

83.80

u/l

0.25

204

879

Peripheral arterial reconstruction

376

2.27

11.34

1.2

1.1

127.64

87.74

u/l

1.49

329

Soft tissue disorders

401

1389

1.48

11.33

1.2

1.1

81.46

84.15

u/l

0.23

354

1234

Unspecified haematuria

188

883

1.74

11.28

1.1

87.92

83.97

u/l

0.32

167

786

Zoster [herpes zoster], including avohilmo

250

1510

1.60

11.28

1.2

1.1

85.10

83.79

u/l

0.11

223

1339

Haemorrhage from respiratory passages

153

738

1.84

11.27

1.2

1.1

89.35

85.35

u/l

0.30

135

656

Pain (limb, back, neck, head abdominally)

283

888

1.60

11.25

1.1

85.75

84.72

u/l

0.05

248

794

Viral infections characterized by skin and mucous membrane lesions

190

1110

1.72

11.24

1.2

1.1

89.97

83.31

u/l

0.58

170

986

Candidiasis, including avohilmo

147

799

1.85

11.16

1.2

1.1

88.45

80.25

u/l

0.58

127

711

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

389

2075

1.46

11.14

1.2

1.1

83.36

82.86

u/l

0.05

349

1851

Carbimazole or st.post thyroidectomy, condition for graves disease

111

550

2.03

11.10

1.1

1.2

72.85

78.31

u/l

0.57

105

494

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

418

2.19

11.09

1.2

1.1

121.54

82.88

u/l

1.50

359

Disorders of synovium and tendon

237

1241

1.62

11.09

1.1

92.31

84.03

u/l

0.52

213

1102

Malignant neoplasm of breast, HER-negative

104

482

2.08

11.09

1.1

75.79

74.10

u/l

0.12

409

Seronegative rheumatoid arthritis

246

2.58

11.06

1.1

68.64

83.45

u/l

1.26

217

Genitourinary diseases

190

539

1.77

10.99

1.2

86.55

81.92

u/l

0.24

170

479

Functional dyspepsia

131

690

1.91

10.98

1.2

1.1

84.94

80.44

u/l

0.29

112

619

Diseases of the eye and adnexa

294

937

1.57

10.97

1.2

1.1

81.92

78.81

u/l

0.24

267

841

Corns and callosities

127

3.26

10.95

1.4

1.1

107.76

80.68

u/l

0.51

116

Other interstitial pulmonary diseases

371

2.25

10.83

1.2

1.1

90.03

85.19

u/l

0.20

328

Zoster [herpes zoster]

101

488

2.08

10.83

1.2

1.1

91.18

82.78

u/l

0.44

431

ILD, hospital admissions 1, main diag only

309

2.38

10.81

1.2

1.1

86.00

87.06

u/l

0.03

272

Interstitial lung disease endpoints

372

2.25

10.77

1.2

1.1

90.03

85.16

u/l

0.20

329

Interstitial lung disease

372

2.25

10.77

1.2

1.1

90.03

85.16

u/l

0.20

329

Headache

251

1221

1.59

10.67

1.1

79.06

78.61

u/l

0.03

220

1102

Disorders of vitreous body and globe

256

1544

1.57

10.66

1.2

1.1

86.15

84.41

u/l

0.12

235

1365

Other joint disorders

336

1159

1.51

10.65

1.2

74.81

82.93

u/l

1.80

296

1037

Cholecystitis

299

2.39

10.63

1.1

111.71

77.80

u/l

1.45

266

Sensorineural hearing loss

338

1509

1.50

10.62

1.2

1.1

88.49

84.73

u/l

0.29

302

1331

Malignant neoplasm of prostate

105

294

2.12

10.61

1.2

1.1

69.72

91.76

u/l

2.53

256

ILD, hospital admissions

362

2.25

10.59

1.2

1.1

88.96

84.10

u/l

0.20

319

Depression

402

1864

1.44

10.57

1.2

1.1

81.03

82.85

u/l

0.16

348

1680

Gastric ulcer

407

2.17

10.56

1.1

1.2

107.89

88.13

u/l

1.04

353

Acute pancreatitis

421

2.15

10.50

1.2

1.1

109.09

79.31

u/l

1.05

370

Fentanyl

217

2.64

10.50

1.1

111.75

85.91

u/l

0.75

190

Malignant neoplasm of breast, ER-negative, including Hilmo

108

504

2.01

10.50

1.1

75.67

74.24

u/l

0.10

429

Chronic lower respiratory diseases

499

1883

1.40

10.46

1.1

82.37

82.74

u/l

0.04

452

1678

Disorders of vitreous body

250

1516

1.57

10.46

1.2

1.1

86.45

84.44

u/l

0.14

230

1346

Arthropathies

344

1159

1.50

10.44

1.2

79.85

82.93

u/l

0.31

316

1037

malignant neoplasm of male genital organs, including Hilmo

107

309

2.09

10.43

1.2

1.1

68.92

92.51

u/l

3.01

271

malignant neoplasm of male genital organs

106

306

2.09

10.42

1.2

1.1

69.39

92.85

u/l

2.91

268

Coronary atherosclerosis

282

1149

1.55

10.38

1.1

105.05

81.40

u/l

2.62

255

1017

Atherosclerosis, excluding cerebral and coronary sclerosis

189

878

1.70

10.36

1.2

1.1

117.24

83.47

u/l

2.58

172

757

Anxiety disorders, excluding more controls

347

1501

1.48

10.27

1.2

1.1

88.94

79.97

u/l

0.82

314

1352

Other reaction to severe stress, and adjustment disorders

157

894

1.76

10.22

1.2

1.1

100.22

77.75

u/l

1.48

148

807

Lower back pain or/and sciatica

453

2004

1.41

10.21

1.1

75.43

85.14

u/l

2.25

400

1791

Problems related to lifestyle

159

2.91

10.21

1.2

1.1

111.35

88.36

u/l

0.34

145

Diseases of pulp and periapical tissues, including avohilmo

421

1521

1.43

10.16

1.2

1.1

81.40

84.45

u/l

0.29

377

1360

Any mental disorder

456

1618

1.41

10.12

1.2

1.1

87.29

81.05

u/l

0.66

406

1449

Major coronary heart disease event excluding revascularizations

260

1097

1.57

10.11

1.1

109.60

79.82

u/l

2.89

234

967

Type of accident

134

731

1.84

10.11

1.2

1.1

97.40

80.77

u/l

0.69

115

650

Weight loss

222

2.59

10.10

1.0

1.1

78.83

82.57

u/l

0.16

197

Myocardial infarction, without ST-elevation

180

961

1.70

10.09

1.1

117.45

85.25

u/l

2.24

160

840

Myocardial infarction, strict

198

841

1.67

10.09

1.1

115.88

81.37

u/l

2.49

175

733

Viral pneumonia

258

2.46

10.05

1.2

1.1

102.67

82.91

u/l

0.76

231

Acute upper respiratory infections

447

1908

1.41

9.99

1.2

1.1

82.01

83.48

u/l

0.16

406

1693

Malignant neoplasm of prostate, including Hilmo

104

297

2.07

9.95

1.2

1.1

69.77

91.68

u/l

2.55

259

Alcoholic liver disease

195

2.69

9.94

1.1

111.52

89.22

u/l

0.64

175

Chronic periodontitis, including avohilmo

429

1942

1.41

9.92

1.2

1.1

77.80

85.27

u/l

1.47

378

1734

Idiopathic gout

184

2.74

9.91

1.0

1.1

97.44

100.69

u/l

0.09

164

Sicca syndrome [Sjögren]

202

2.65

9.83

1.1

1.2

86.27

75.24

u/l

0.70

180

Conductive and sensorineural hearing loss

348

1582

1.46

9.83

1.2

1.1

85.89

84.25

u/l

0.12

312

1402

Falls/tendency to fall

426

1504

1.42

9.76

1.2

1.1

89.77

80.77

u/l

1.11

375

1359

Pyogenic arthritis

126

3.12

9.75

1.2

1.1

86.68

90.39

u/l

0.10

114

Dental operations

236

756

1.61

9.74

1.1

82.63

86.73

u/l

0.34

213

683

Acute bronchitis

180

1059

1.67

9.73

1.2

1.1

87.68

82.57

u/l

0.41

159

938

Periodontitis

428

1943

1.41

9.68

1.2

1.1

77.89

85.22

u/l

1.43

379

1735

Ischaemic heart disease, wide definition

344

1449

1.46

9.63

1.2

1.1

101.96

80.34

u/l

2.56

308

1288

Viral and other specified intestinal infections

336

2.21

9.59

1.3

1.2

101.65

74.25

u/l

0.82

302

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

333

2.24

9.55

1.1

96.11

83.00

u/l

0.80

288

Mood [affective] disorders

425

1942

1.40

9.55

1.2

1.1

82.02

83.02

u/l

0.08

370

1748

Mood disorders

426

1945

1.40

9.52

1.2

1.1

81.96

83.01

u/l

0.09

371

1751

Secondary uncertain malignant neoplasm

271

2.38

9.51

1.2

1.1

124.52

77.99

u/l

2.47

233

Disease of hard tissues of teeth, NOS

224

727

1.62

9.47

1.2

1.1

79.17

90.75

u/l

0.98

193

652

Benign neoplasms

379

1436

1.44

9.46

1.2

1.1

89.70

82.50

u/l

0.66

339

1285

Neurological diseases

327

1108

1.48

9.42

1.2

1.1

85.42

82.40

u/l

0.21

294

992

Other acute lower respiratory infections

222

1348

1.57

9.33

1.2

1.1

91.48

83.89

u/l

0.67

199

1201

Other metabolic disorders

311

2.26

9.33

1.1

1.2

93.95

73.84

u/l

0.59

279

Depression or dysthymia

275

983

1.53

9.33

1.2

81.35

83.39

u/l

0.16

241

891

Diverticular disease of intestine

308

1294

1.48

9.29

1.2

1.1

79.70

84.90

u/l

0.58

264

1158

Oesophageal varices

3.67

9.28

1.1

1.2

139.13

80.99

u/l

1.72

Mental and behavioural disorders due to tobacco

185

2.67

9.27

1.1

82.12

77.19

u/l

0.23

169

Smoking dependency

185

2.67

9.27

1.1

82.12

77.99

u/l

0.19

169

Candidiasis

331

2.22

9.27

1.2

86.67

76.87

u/l

0.53

297

Excessive earwax

280

1703

1.49

9.23

1.1

81.44

85.36

u/l

0.30

246

1510

Fibromyalgia

209

2.55

9.19

1.3

1.1

73.12

73.72

u/l

0.03

192

Other or unspecified ileus, impaction or obstruction

424

2.06

9.17

1.3

1.1

88.48

85.44

u/l

0.10

375

Benign neoplasm of colon, rectum, anus and anal canal

288

1645

1.48

9.11

1.2

1.1

90.58

84.13

u/l

0.72

255

1457

Urinary track infection

260

845

1.54

9.02

1.2

1.1

75.65

77.85

u/l

0.23

228

765

Gonarthrosis

272

1014

1.52

8.98

1.1

84.48

86.15

u/l

0.11

238

904

Pruritus

267

2.34

8.91

1.2

1.1

80.14

75.79

u/l

0.24

237

Polyarthrosis

108

514

1.90

8.90

1.1

78.10

84.43

u/l

0.39

450

Exposure to other specified factors

334

2004

1.43

8.87

1.2

1.1

82.96

82.16

u/l

0.06

296

1795

Concussion

193

929

1.61

8.81

1.2

1.1

82.19

80.76

u/l

0.07

163

838

Fibrosis of liver

12.12

8.68

1.3

1.2

135.00

78.01

u/l

1.21

Pacemaker

161

903

1.66

8.51

1.1

91.17

87.64

u/l

0.27

142

782

Internal derangement of knee

158

944

1.66

8.43

1.2

73.66

85.05

u/l

1.87

149

843

Disorders of sclera, cornea, iris and ciliary body

233

1542

1.51

8.41

1.1

78.10

83.40

u/l

0.63

214

1376

Pain associated with micturition

275

2.27

8.35

1.2

1.1

68.82

77.38

u/l

0.72

250

Other respiratory disorders and diseases

511

1.91

8.26

1.2

1.1

98.89

89.86

u/l

0.36

446

Other diseases of the respiratory system

511

1.91

8.26

1.2

1.1

98.89

89.86

u/l

0.36

446

Conduction disorders

124

559

1.78

8.23

1.1

89.75

79.98

u/l

0.92

112

493

Bronchitis

447

1976

1.36

8.23

1.2

1.1

86.98

82.15

u/l

0.65

404

1756

Adalimumab

191

2.53

8.21

1.1

73.59

75.43

u/l

0.06

179

Postprocedural endocrine and metabolic disorders, not elsewhere classified

290

2.22

8.19

1.1

1.2

96.10

73.02

u/l

0.64

264

Diseases of the musculoskeletal system and connective tissue

179

546

1.65

8.15

1.2

1.1

71.52

83.88

u/l

1.88

165

485

Psoriasis vulgaris

444

1.97

8.14

1.2

1.1

80.74

83.23

u/l

0.10

400

Other CVD

521

1.89

8.12

1.1

95.11

85.49

u/l

0.30

457

Abnormalities of heart beat

150

875

1.67

8.10

1.1

82.61

83.09

u/l

0.03

137

784

Benign neoplasm: Colon

244

1541

1.49

8.06

1.2

1.1

90.24

83.88

u/l

0.65

221

1358

Other skin changes

523

1.88

8.04

1.2

1.1

107.04

84.25

u/l

0.84

456

Congenital malformations, deformations and chromosomal abnormalities

227

1428

1.51

8.03

1.2

1.1

83.46

81.28

u/l

0.12

209

1284

Rheumatism, unspecified

353

2.08

7.95

1.1

74.44

74.98

u/l

0.02

314

Acute pancreatitis (for exclusion)

469

1.93

7.94

1.2

1.1

109.09

85.35

u/l

0.76

416

Viral and other specified intestinal infections, including avohilmo

511

1.87

7.93

1.3

1.2

92.80

77.50

u/l

0.51

457

Coxarthrosis

216

906

1.54

7.92

1.1

82.11

85.58

u/l

0.24

188

808

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

330

2.10

7.88

1.2

1.1

73.33

85.02

u/l

0.59

298

Cystitis

349

1480

1.40

7.87

1.1

78.31

85.34

u/l

1.19

313

1330

Abnormal spermatozoa

238

2.33

7.86

1.2

1.1

70.78

110.86

u/l

3.68

210

Neurotic, stress-related and somatoform disorders

359

1780

1.39

7.86

1.2

1.1

89.19

80.34

u/l

0.85

325

1596

Malignant neoplasm of digestive organs, including Hilmo

165

748

1.63

7.75

1.1

97.68

81.51

u/l

1.54

158

641

Injuries to the elbow and forearm

300

1811

1.42

7.72

1.2

1.1

76.76

83.56

u/l

1.10

261

1624

Other diseases of hard tissues of teeth

218

734

1.54

7.65

1.1

84.60

90.67

u/l

0.37

200

659

Retention of urine

138

665

1.68

7.54

1.1

102.75

85.57

u/l

0.90

120

593

Non-selective monoamine reuptake inhibitors

169

1026

1.58

7.48

1.1

77.12

87.23

u/l

1.07

146

913

Chronic gastritis

120

697

1.73

7.46

1.1

78.86

85.68

u/l

0.57

100

616

Anxiety disorders

360

1796

1.38

7.44

1.2

1.1

89.13

80.76

u/l

0.78

326

1609

Caries of dentine, including avohilmo

303

1083

1.43

7.43

1.1

80.73

84.20

u/l

0.27

277

974

Use of hypnotics and sedatives

430

1830

1.34

7.40

1.2

1.1

82.75

83.55

u/l

0.08

383

1635

Symptoms and signs involving the nervous and musculoskeletal systems

246

1691

1.46

7.40

1.2

1.1

83.80

82.20

u/l

0.10

220

1498

Spondylopathies

329

1389

1.40

7.40

1.2

1.1

82.85

86.40

u/l

0.26

287

1238

Acute sinusitis

210

1271

1.50

7.32

1.1

77.14

81.02

u/l

0.40

192

1133

Malignant neoplasm of skin

195

856

1.54

7.32

1.2

1.1

84.09

81.00

u/l

0.22

175

735

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

307

2.09

7.31

1.2

1.1

73.27

83.41

u/l

0.46

277

Dysphagia

105

591

1.78

7.30

1.2

1.1

89.46

82.80

u/l

0.38

525

Factors influencing health status and contact with health services

234

1.96

7.29

1.2

1.1

83.32

84.68

u/l

0.05

202

Symptoms and signs involving the skin and subcutaneous tissue

303

2047

1.40

7.26

1.2

1.1

84.88

83.02

u/l

0.13

279

1813

Disorders of eyelid, lacrimal system and orbit

364

1955

1.37

7.25

1.2

1.1

78.39

84.17

u/l

0.94

331

1734

Abnormal weight loss

204

2.37

7.19

1.0

1.2

83.17

83.18

u/l

0.00

180

Biguanides

393

1755

1.35

7.16

1.1

87.67

82.32

u/l

0.63

350

1570

Pulmonary heart disease, diseases of pulmonary circulation

140

857

1.64

7.16

1.2

1.1

98.04

82.47

u/l

1.54

127

748

Other gastritis (incl. Duodenitis)

523

1.82

7.12

1.2

1.1

104.56

84.30

u/l

0.71

462

Keratitis

151

947

1.60

7.02

1.1

80.33

84.38

u/l

0.35

139

840

Otitis externa

556

1.79

6.96

1.1

90.36

81.76

u/l

0.29

496

Autoimmune hyperthyroidism

113

2.85

6.95

1.1

74.55

78.51

u/l

0.17

100

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

102

571

1.77

6.92

1.2

1.1

72.34

80.23

u/l

0.90

516

Other disorders of lacrimal gland

172

1118

1.54

6.86

1.2

1.1

75.48

83.87

u/l

1.00

156

992

Benign neoplasm of other and ill-defined parts of digestive system

473

1.85

6.81

1.1

88.32

85.04

u/l

0.20

419

Malignant neoplasm of skin, including Hilmo

201

894

1.51

6.80

1.2

1.1

84.61

80.71

u/l

0.31

181

769

Pleural effusion

368

1.97

6.79

1.1

120.15

85.32

u/l

2.02

323

Diseases of oral cavity, salivary glands and jaws

215

739

1.50

6.75

1.1

76.90

90.71

u/l

2.07

196

663

Cerebrovascular diseases

306

1530

1.39

6.74

1.2

1.1

99.93

83.32

u/l

1.74

272

1357

Degeneration of macula and posterior pole

208

1082

1.49

6.72

1.2

1.1

91.11

82.45

u/l

0.93

179

946

Substance abuse, excluding more controls

210

1188

1.48

6.71

1.1

102.15

81.46

u/l

1.57

182

1070

Polycystic ovarian syndrome, consortium definition

303

1245

1.40

6.71

1.2

1.1

70.73

78.29

u/l

1.91

272

1111

Hypotension

412

1.90

6.68

1.1

97.62

85.74

u/l

0.29

363

Fracture of rib(s), sternum and thoracic spine

131

804

1.63

6.68

1.1

89.66

86.19

u/l

0.11

117

709

Early onset COPD, excluding more controls

426

1.88

6.66

1.2

1.1

87.93

83.38

u/l

0.21

370

Disorders of skin appendages

196

1313

1.49

6.61

1.1

79.16

81.83

u/l

0.15

183

1172

Other diseases of upper respiratory tract

439

1737

1.32

6.56

1.2

1.1

78.76

84.89

u/l

0.85

387

1552

Other external causes of accidental injury

309

1113

1.39

6.53

1.2

1.1

84.21

80.74

u/l

0.25

275

1004

Symptoms and signs involving cognition, perception, emotional state and behaviour

389

1954

1.33

6.53

1.1

86.01

82.89

u/l

0.25

343

1746

Alcohol use disorder, Swedish definition

206

1274

1.47

6.51

1.1

1.2

104.40

82.75

u/l

1.37

182

1144

Postprocedural musculoskeletal disorders, not elsewhere classified

164

2.46

6.51

1.2

76.24

79.34

u/l

0.13

147

Examination and observation for other reasons

193

719

1.52

6.50

1.2

1.1

90.97

82.07

u/l

0.51

181

617

Dorsalgia

379

1496

1.34

6.49

1.2

1.1

75.84

84.92

u/l

1.58

337

1334

Arthrosis

274

1062

1.42

6.47

1.1

84.52

85.59

u/l

0.06

242

950

Gingivitis and periodontal diseases

391

1511

1.34

6.47

1.1

77.36

87.50

u/l

1.90

350

1348

Fracture of foot, except ankle

104

607

1.72

6.43

1.2

81.81

76.86

u/l

0.36

550

Accidents

308

1113

1.39

6.39

1.2

1.1

83.98

80.74

u/l

0.23

275

1004

Any death

269

1344

1.40

6.31

1.2

1.1

126.00

77.66

u/l

5.86

249

1179

Respiratory insufficiency

154

2.47

6.30

1.1

89.81

82.36

u/l

0.25

133

Selective serotonin reuptake inhibitors

382

1489

1.34

6.26

1.1

76.86

85.68

u/l

1.55

334

1334

Mycoses, including avohilmo

366

2096

1.33

6.26

1.1

86.36

82.41

u/l

0.36

321

1875

Other malignant neoplasms of skin (=non-melanoma skin cancer)

175

781

1.52

6.26

1.2

1.1

82.61

82.75

u/l

0.01

155

665

Primary gonarthrosis, bilateral

234

1375

1.43

6.24

1.1

83.04

85.22

u/l

0.20

198

1220

Injuries to the ankle and foot

281

1739

1.38

6.23

1.2

1.1

85.98

79.45

u/l

0.51

247

1566

Injuries to the thorax

185

1248

1.48

6.20

1.2

1.1

86.06

84.13

u/l

0.08

165

1107

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

244

1577

1.41

6.19

1.2

1.1

85.90

80.46

u/l

0.39

225

1411

Myalgia

101

592

1.71

6.17

1.1

85.50

80.84

u/l

0.27

526

Stroke, excluding SAH

245

1249

1.42

6.16

1.1

103.90

82.92

u/l

1.86

210

1108

Polyp of the female genital tract

139

489

1.61

6.14

1.2

1.1

83.39

81.77

u/l

0.09

117

442

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

179

804

1.50

6.05

1.2

1.1

82.23

81.91

u/l

0.02

162

686

Open wound of head

217

1424

1.43

6.04

1.1

92.13

82.03

u/l

1.20

186

1277

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

388

1863

1.32

6.04

1.2

1.1

88.50

82.99

u/l

0.77

344

1671

Other (seronegative) rheumatoid arthritis, wide

500

1.77

6.02

1.1

74.22

83.14

u/l

0.82

438

External causes of morbidity and mortality

239

836

1.43

6.01

1.2

1.1

74.45

81.42

u/l

0.95

215

745

Stroke, including SAH

260

1339

1.40

5.98

1.1

100.39

84.64

u/l

1.31

226

1191

Other diseases of oesophagus

177

2.33

5.98

1.1

1.2

107.31

91.80

u/l

0.21

161

Type 1 diabetes, strict (exclude DM2)

117

2.65

5.94

1.1

80.48

71.43

u/l

0.42

111

Undetermined asthma, excluding more controls

262

2.07

5.91

1.1

72.34

75.71

u/l

0.15

229

Disorders of lacrimal system

197

1340

1.45

5.86

1.2

1.1

76.41

84.21

u/l

1.01

181

1186

Type 1 diabetes, definitions combined

118

2.63

5.85

1.1

80.48

71.27

u/l

0.43

112

226

1390

1.42

5.84

1.1

1.2

103.77

82.62

u/l

1.48

199

1247

Asthma-related infections

234

1630

1.40

5.79

1.1

86.27

84.18

u/l

0.15

215

1443

Asthma, hospital admission 2, infections

234

1630

1.40

5.79

1.1

86.27

84.18

u/l

0.15

215

1443

Gonarthrosis,primary

374

1715

1.32

5.76

1.1

81.19

84.31

u/l

0.30

328

1533

Alcohol-induced chronic pancreatitis

108

2.70

5.76

1.1

1.2

115.57

92.94

u/l

0.31

101

Exclusions for E4_PCOS_CONSORTIUM

288

1316

1.37

5.76

1.2

1.1

76.63

80.71

u/l

0.33

265

1175

Diagnoses used for exclusion with ILD

105

635

1.66

5.74

1.1

93.92

83.87

u/l

0.59

560

Acute upper respiratory infections of multiple and unspecified sites

300

1620

1.35

5.73

1.2

1.1

84.59

82.94

u/l

0.15

275

1446

Calcific aortic valvular stenosis, including rheumatic fever

121

729

1.60

5.70

1.1

104.41

88.87

u/l

0.74

106

636

Uterine polyps

131

479

1.60

5.70

1.1

84.56

81.79

u/l

0.13

108

432

Hypertensive Heart Disease

409

1.73

5.67

1.2

1.1

98.65

79.16

u/l

1.02

356

Infliximab

4.79

5.63

1.3

1.2

50.29

96.38

u/l

2.30

Pulmonary embolism

124

787

1.58

5.58

1.2

1.1

97.28

82.99

u/l

1.20

113

687

Other abnormal uterine and vaginal bleeding

106

459

1.66

5.57

1.2

1.1

79.48

82.22

u/l

0.15

412

Fracture of forearm

234

1511

1.39

5.55

1.2

1.1

78.57

83.82

u/l

0.60

205

1347

Urticaria and erythema

146

963

1.52

5.53

1.2

1.1

86.39

80.05

u/l

0.54

135

854

Polymyalgia rheumatica

304

1.95

5.52

1.1

89.53

79.27

u/l

0.36

259

L01XE Protein kinase inhibitors

105

2.69

5.50

1.1

145.93

81.48

u/l

1.84

Dental caries, including avohilmo

274

1021

1.38

5.49

1.1

80.95

84.86

u/l

0.28

250

920

Calcific aortic valvular stenosis

120

730

1.59

5.48

1.1

104.77

88.84

u/l

0.76

105

637

Calcific aortic valvular stenosis, operated

120

730

1.59

5.48

1.2

1.1

104.77

88.84

u/l

0.76

105

637

Calcific aortic valvular stenosis, diagnosis (helper)

120

730

1.59

5.48

1.2

1.1

104.77

88.84

u/l

0.76

105

637

Operations 2 for CAVS

120

730

1.59

5.48

1.1

104.77

88.84

u/l

0.76

105

637

Pulmonary heart disease

124

791

1.57

5.47

1.2

1.1

97.28

83.30

u/l

1.17

113

691

Substance use, excluding alcohol

420

1.79

5.42

1.2

1.1

80.48

81.09

u/l

0.03

382

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

327

1.90

5.42

1.2

1.1

72.43

78.12

u/l

0.38

304

Coeliac disease

258

2.02

5.41

1.3

1.1

98.11

76.14

u/l

0.47

232

Ischaemic Stroke, excluding all haemorrhages

225

1183

1.40

5.39

1.1

102.03

83.20

u/l

1.48

190

1046

Psychiatric diseases

375

1437

1.31

5.38

1.2

1.1

87.79

81.45

u/l

0.57

340

1291

Infective dermatitis

239

2.06

5.35

1.1

121.01

91.57

u/l

0.57

216

Sarcoidosis

308

1.92

5.33

1.1

88.97

78.13

u/l

0.67

278

Personality disorders, excluding more controls

510

1.71

5.32

1.2

1.1

90.75

81.78

u/l

0.25

460

Venous thromboembolism

220

1522

1.39

5.31

1.2

1.1

87.89

84.31

u/l

0.31

200

1350

COPD (mode)

115

563

1.60

5.24

1.2

1.1

88.75

82.36

u/l

0.41

485

Aortic valve malfunction, age under 60 years

188

2.19

5.24

1.2

1.1

121.44

87.68

u/l

0.66

175

DVT of lower extremities and pulmonary embolism

171

1174

1.45

5.23

1.2

1.1

91.28

85.39

u/l

0.47

157

1034

Shoulder lesions

287

1278

1.35

5.22

1.2

1.1

83.04

85.64

u/l

0.18

262

1136

Gonarthrosis, primary, with knee surgery

251

1432

1.37

5.22

1.1

83.33

84.73

u/l

0.11

219

1270

Mental and behavioural disorders due to psychoactive substance use

220

1451

1.39

5.21

1.1

1.2

101.66

82.21

u/l

1.53

191

1304

Systemic sclerosis

3.52

5.19

1.2

85.18

78.09

u/l

0.18

Basal cell carcinoma, including Hilmo

170

785

1.47

5.19

1.2

1.1

78.49

82.55

u/l

0.32

153

668

Excessive attrition of teeth

236

1706

1.37

5.18

1.1

1.2

78.52

82.38

u/l

0.41

209

1528

Moderate visual impairment, binocular

3.37

5.17

1.3

1.1

88.39

77.35

u/l

0.19

Acute suppurative otitis media

431

1.73

5.14

1.2

88.42

72.65

u/l

0.52

392

Undetermined asthma

277

1.96

5.12

1.1

72.34

83.76

u/l

0.58

243

Other and unspecified urticaria

450

1.74

5.12

1.2

90.50

73.77

u/l

1.29

402

Injuries to the head

430

2010

1.27

5.10

1.1

90.16

81.25

u/l

0.96

360

1815

Other disorders of conjunctiva

363

1.83

5.09

1.1

68.29

82.35

u/l

1.54

322

Primary coxarthrosis, bilateral

124

807

1.54

5.05

1.2

1.1

78.71

85.26

u/l

0.36

108

710

Erythema intertrigo

3.44

5.04

1.2

91.94

88.95

u/l

0.03

Other diseases of intestine

358

1.82

5.00

1.1

78.04

86.75

u/l

0.55

315

Contact with and exposure to communicable diseases

602

1.62

5.00

1.2

78.62

75.11

u/l

0.21

552

Haemorrhoids and perianal venous thrombosis

136

900

1.50

4.95

1.2

1.1

91.68

84.68

u/l

0.54

125

799

Diseases of pulp and periapical tissues and dental caries

240

894

1.38

4.93

1.2

77.20

85.09

u/l

0.91

219

807

209

1346

1.39

4.92

1.1

1.2

101.27

82.94

u/l

1.33

184

1210

Follow-up examination after treatment for malignant neoplasms

220

2.06

4.91

1.1

81.05

82.04

u/l

0.04

182

169

1171

1.43

4.86

1.1

81.83

82.24

u/l

0.02

155

1041

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

572

1.63

4.85

1.1

1.2

82.04

78.51

u/l

0.24

519

Anxiety (asthma-related co-morbidities)

219

1210

1.38

4.81

1.2

90.34

77.40

u/l

0.93

194

1098

Intracranial injury

223

1523

1.37

4.79

1.2

1.1

86.34

81.78

u/l

0.27

189

1367

Substance abuse

210

1417

1.38

4.77

1.1

1.2

102.15

82.44

u/l

1.46

182

1276

severe traumatic brain injury, does not include concussion

528

1.65

4.77

1.2

1.1

94.86

88.82

u/l

0.24

468

Ventral hernia

101

638

1.59

4.72

1.2

1.1

86.72

83.59

u/l

0.13

564

Somatoform disorder

373

1.78

4.69

1.1

74.76

75.93

u/l

0.04

337

Hernia of abdominal wall

174

1232

1.42

4.67

1.2

1.1

92.56

84.42

u/l

0.45

161

1095

Superficial injury of hip and thigh

330

1.82

4.65

1.3

1.1

93.75

79.07

u/l

0.63

299

Status epilepticus

3.13

4.64

1.2

79.22

90.22

u/l

0.29

Systemic sclerosis, icd10

3.25

4.63

1.2

85.18

80.29

u/l

0.12

Glucagon-like peptide-1 (GLP-1) analogues

124

824

1.51

4.63

1.1

1.2

82.53

82.90

u/l

0.02

110

742

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

124

824

1.51

4.63

1.1

1.2

82.53

82.90

u/l

0.02

110

742

Malignant melanoma, including Hilmo

382

1.76

4.62

1.3

1.1

87.52

82.77

u/l

0.16

328

Bacterial, viral and other infectious agents

140

2.30

4.60

1.3

1.2

117.39

79.78

u/l

1.05

132

Carpal tunnel syndrome

249

1617

1.34

4.60

1.2

1.1

83.35

83.19

u/l

0.01

222

1437

Speech and linguistic disorders, excluding more controls

2.59

4.57

1.2

77.93

77.88

u/l

0.00

Traumatic subdural haemorrhage

283

1.86

4.56

1.1

108.48

83.22

u/l

1.00

246

Suppurative and unspecified otitis media

114

659

1.53

4.54

1.2

98.35

78.80

u/l

0.74

106

592

Asthma-related pneumonia

144

987

1.46

4.53

1.1

91.34

84.42

u/l

0.44

134

868

Asthma, hospital admissions 3, pneumonia

144

987

1.46

4.53

1.1

91.34

84.42

u/l

0.44

134

868

Asthma-related pneumonia or sepsis

144

987

1.46

4.53

1.1

91.34

84.42

u/l

0.44

134

868

Left ventricular outflow tract obstruction (LVOTO), broad definition

200

2.06

4.53

1.2

1.1

121.44

87.81

u/l

0.66

185

Myocardial infarction, unclassifiable

436

1.66

4.51

1.1

117.73

88.65

u/l

0.88

381

Other other unspecified disorders of the circulatory system

2.88

4.50

1.1

1.2

86.95

83.48

u/l

0.10

122

696

1.51

4.48

1.2

1.1

93.64

86.62

u/l

0.41

105

603

Colectomy operation

416

1.71

4.47

1.2

1.1

98.06

88.46

u/l

0.34

369

Acute and subacute iridocyclitis

455

1.68

4.42

1.2

1.1

76.09

83.74

u/l

0.44

405

Chronic periodontitis, complicated

229

1669

1.34

4.39

1.2

1.1

78.96

85.39

u/l

0.84

203

1490

Persons with potential health hazards related to communicable diseases

123

818

1.49

4.38

1.2

81.71

77.74

u/l

0.27

103

745

Benign neoplasm: Colon, unspecified

105

683

1.54

4.36

1.1

98.72

85.93

u/l

0.73

601

Common variable immunodeficiency

9.16

4.31

2.0

1.1

160.75

53.01

u/l

—

Benign paroxysmal vertigo

126

854

1.48

4.31

1.1

79.32

83.27

u/l

0.26

116

752

Basal cell carcinoma

161

771

1.43

4.30

1.2

1.1

77.93

82.84

u/l

0.38

143

656

Fissure and fistula of anal and rectal regions

559

1.60

4.30

1.1

74.43

83.39

u/l

1.00

498

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

102

662

1.54

4.28

1.2

72.34

79.07

u/l

0.75

605

Artrosis, including avohilmo

306

1294

1.30

4.27

1.1

78.82

87.94

u/l

1.48

274

1164

Paralytic ileus

2.86

4.23

1.3

1.1

99.68

92.80

u/l

0.14

Malignant melanoma

341

1.77

4.22

1.3

1.1

87.43

78.90

u/l

0.30

293

Disorders of conjunctiva

318

1931

1.28

4.20

1.2

1.1

76.08

83.55

u/l

1.27

298

1712

All anxiety disorders

222

1290

1.34

4.12

1.1

1.2

89.90

77.81

u/l

0.86

196

1163

169

1095

1.39

4.10

1.2

1.1

84.71

85.41

u/l

0.04

150

956

L02BB Anti-androgens

181

2.05

4.09

1.3

1.1

73.00

103.49

u/l

1.38

160

Iridocyclitis

559

1.58

4.08

1.2

1.1

74.66

83.19

u/l

0.59

492

Obesity related asthma

138

963

1.44

4.08

1.1

72.94

84.88

u/l

2.01

126

858

Infections with a predominantly sexual mode of transmission

103

677

1.52

4.05

1.2

102.39

74.73

u/l

1.34

621

Other viral diseases

637

1.54

4.03

1.2

82.73

80.84

u/l

0.10

575

Adjustment and management of implanted device

384

1.70

4.01

1.0

1.1

89.25

90.70

u/l

0.07

333

Provisional assignment of new diseases of uncertain etiology

199

1468

1.35

4.00

1.2

1.1

95.28

81.53

u/l

1.33

186

1296

Asthma (diagnoses ohter than nonallergic)

330

2115

1.26

3.98

1.1

1.2

79.36

83.79

u/l

0.65

299

1881

Codes for special purposes

199

1469

1.34

3.98

1.2

1.1

95.28

81.53

u/l

1.33

186

1297

525

1.57

3.94

1.2

1.1

94.19

86.74

u/l

0.37

456

SLE (Finngen)

2.90

3.90

1.1

90.00

86.38

u/l

0.09

Diseases of inner ear

219

1587

1.32

3.89

1.1

80.36

84.78

u/l

0.40

202

1402

L02BA Anti-estrogens

472

1.62

3.89

1.2

78.87

75.06

u/l

0.17

420

Actinic keratosis

156

1019

1.40

3.89

1.2

1.1

86.70

85.45

u/l

0.06

138

884

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

252

1.85

3.88

1.2

1.1

95.79

83.59

u/l

0.60

214

Malignant neoplasm of digestive organs

132

701

1.44

3.86

1.1

96.77

81.81

u/l

1.05

126

599

Unspecified fall

194

1420

1.34

3.85

1.2

1.1

87.89

83.51

u/l

0.24

175

1258

Injuries to the knee and lower leg

447

1977

1.22

3.85

1.1

86.19

81.80

u/l

0.49

403

1759

Seropositive rheumatoid arthritis, strict definition

374

1.69

3.84

1.2

1.1

68.81

77.55

u/l

0.90

333

Suicide or other Intentional self-harm

560

1.56

3.83

1.2

71.92

80.85

u/l

0.92

507

Alzheimer disease

696

0.59

3.82

1.1

102.12

86.93

u/l

0.71

597

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

194

1397

1.34

3.81

1.1

1.2

82.54

83.65

u/l

0.05

170

1254

Other hearing loss

107

698

1.49

3.80

1.3

1.1

96.99

86.94

u/l

0.35

602

Other or unspecified common variable immunodeficiency

12.51

3.80

2.3

1.0

161.50

45.22

u/l

—

Irregular menses

189

1052

1.35

3.78

1.2

1.1

71.81

74.59

u/l

0.40

174

944

Specific personality disorders

499

1.59

3.78

1.2

91.63

77.57

u/l

0.38

455

Benign thyroid growths and nodules

135

884

1.42

3.77

1.1

72.72

84.77

u/l

2.31

118

789

Fracture of lower leg, including ankle

214

1595

1.32

3.77

1.1

92.67

82.59

u/l

0.70

188

1416

Alzheimer disease, including avohilmo

791

0.63

3.75

1.1

96.34

86.43

u/l

0.51

675

Skin changes due to chronic exposure to nonionizing radiation

159

1044

1.38

3.75

1.2

1.1

85.84

85.29

u/l

0.03

141

909

Anterior Iridocyclitis

493

1.59

3.73

1.2

1.1

75.71

82.81

u/l

0.41

437

Poisoning by medicine

462

1.61

3.72

1.2

1.1

74.26

78.88

u/l

0.31

422

Procreative management

122

695

1.45

3.71

1.2

75.37

78.13

u/l

0.17

107

628

Amputation of thigh

3.62

3.70

1.2

1.1

86.36

111.88

u/l

0.54

Glaucoma

229

1493

1.30

3.67

1.2

1.1

76.08

87.02

u/l

2.16

190

1330

Artificial joint operation, meniscal resection

356

1837

1.24

3.63

1.1

78.96

85.89

u/l

1.18

310

1645

Malignant neoplasm of bladder, including Hilmo

215

1.89

3.62

1.1

75.23

85.89

u/l

0.54

185

Other neurological diseases

278

1697

1.27

3.62

1.1

87.17

84.75

u/l

0.15

251

1499

Disorders of vestibular function (Vertigo)

189

1383

1.33

3.60

1.1

82.85

84.39

u/l

0.10

175

1227

Other disorders of the musculoskeletal system and connective tissue

366

1.67

3.60

1.2

88.39

84.79

u/l

0.17

328

Obesity, other/unspecified

124

871

1.43

3.59

1.1

80.67

81.03

u/l

0.02

117

789

Presbycusis

310

1.73

3.57

1.1

73.79

91.40

u/l

1.56

259

Degenerative diseases of the nervous system

784

0.63

3.55

1.1

98.39

87.85

u/l

0.51

671

Sequelae of cerebrovascular disease

140

857

1.40

3.54

1.2

1.1

95.32

84.77

u/l

0.65

127

752

Other noninflammatory disorders of vulva and perineum

227

1.86

3.54

1.4

1.1

83.16

75.95

u/l

0.43

205

Coxarthrosis, primary

241

1554

1.29

3.54

1.1

78.21

86.93

u/l

0.97

211

1373

Spinal stenosis

205

1147

1.32

3.51

1.2

1.1

81.10

87.18

u/l

0.46

180

1020

Enthesopathies of lower limb, excluding foot

621

1.50

3.50

1.2

1.1

90.81

84.37

u/l

0.26

555

Other infectious diseases

158

2.04

3.50

1.2

75.97

84.71

u/l

0.42

144

Other headache syndromes

154

1124

1.37

3.49

1.2

1.1

75.90

82.31

u/l

0.66

142

1003

Heartburn

229

1.84

3.45

1.2

77.46

79.29

u/l

0.08

207

Unspecified contracted kidney

7.19

3.39

1.1

1.3

163.57

84.61

u/l

—

Ill-defined and unknown causes of mortality

209

1.87

3.39

1.1

87.09

88.71

u/l

0.05

186

Cardiodefibrillation

131

937

1.40

3.39

1.1

87.79

88.87

u/l

0.06

105

827

Asthma, including avohilmo

439

2004

1.21

3.38

1.1

1.2

82.38

83.44

u/l

0.11

402

1780

Fall on same level involving ice and snow

223

1731

1.29

3.38

1.2

1.1

89.42

82.62

u/l

0.45

197

1544

Open wound of forearm

181

1.94

3.37

1.2

1.1

88.47

83.03

u/l

0.20

163

Other dorsopathies, not elsewhere classified

356

1500

1.23

3.37

1.2

1.1

78.85

84.85

u/l

0.79

324

1338

Other hammer toe(s) (acquired)

416

1.58

3.36

1.2

1.1

79.35

82.41

u/l

0.19

364

268

1.76

3.35

1.2

1.1

125.32

77.75

u/l

0.90

243

Diplopia

313

1.70

3.34

1.2

1.1

82.51

82.68

u/l

0.01

280

Bacterial, viral and other infectious agents, including avohilmo

161

2.00

3.33

1.3

1.2

117.39

78.02

u/l

1.13

150

Urticaria

108

751

1.44

3.33

1.2

1.1

88.90

79.72

u/l

0.69

671

Other diseases of lip and oral mucosa

166

1241

1.34

3.33

1.2

1.1

78.33

82.94

u/l

0.52

147

1110

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

162

1.99

3.29

1.1

1.2

63.26

73.38

u/l

0.54

149

Unspecified mental disorder

136

987

1.38

3.29

1.2

1.1

72.66

83.98

u/l

1.75

118

892

Striking against or struck by other objects

109

760

1.43

3.29

1.2

94.34

83.97

u/l

0.58

100

681

Other/unspecified synovitis and tenosynovitis

255

1.77

3.28

1.0

1.1

115.08

84.89

u/l

0.50

231

Personality disorders

582

1.50

3.27

1.2

90.75

78.38

u/l

0.37

530

Duodenal ulcer

219

1.83

3.26

1.1

82.09

91.31

u/l

0.40

196

Nail disorders

184

1.91

3.23

1.1

1.2

111.03

79.09

u/l

0.54

171

Other/unspecified dorsalgia

143

1037

1.36

3.22

1.1

74.80

83.35

u/l

0.91

127

921

Bipolar affective disorders

378

1.62

3.21

1.3

1.2

97.32

77.44

u/l

0.47

344

Unspecific neurodegenerative disorder

901

0.68

3.21

1.1

81.61

85.84

u/l

0.28

775

Kela-code for severe mental illness

122

875

1.40

3.18

1.2

1.1

73.78

84.71

u/l

1.43

104

788

Dermatophytosis

318

1.67

3.17

1.1

81.42

87.41

u/l

0.18

287

Temporomandibular joint disorders, including avohilmo

162

1178

1.33

3.15

1.2

79.86

77.57

u/l

0.14

142

1065

Coxarthrosis, primary, with hip surgery

187

1328

1.31

3.15

1.1

74.53

86.94

u/l

1.47

166

1170

Barrett oesophagus

2.37

3.15

1.1

1.2

72.95

91.93

u/l

0.84

Phlebitis and thrombophlebitis (not including DVT)

596

1.48

3.13

1.2

1.1

89.96

82.35

u/l

0.33

534

3.46

3.11

1.2

1.1

94.42

82.60

u/l

0.21

Atopic dermatitis, strict definition with reimbursement

604

1.47

3.11

1.2

1.1

77.22

77.33

u/l

0.01

550

Polyuria

541

1.50

3.09

1.1

69.76

85.21

u/l

1.86

479

Other embolism and thrombosis

298

1.68

3.08

1.2

1.1

90.52

80.34

u/l

0.53

270

Other osteochondrodysplasias

5.09

3.07

1.1

85.50

64.56

u/l

—

Diseases of salivary glands

124

900

1.38

3.04

1.1

94.83

81.59

u/l

0.49

114

801

Ganglion

512

1.51

3.01

1.1

74.36

81.63

u/l

0.63

462

Benign neoplasm of other and unspecified endocrine glands

323

1.65

3.01

1.2

1.1

88.58

82.61

u/l

0.18

289

Mental and behavioural disorders due to alcohol

170

1235

1.31

2.98

1.1

1.2

106.47

83.63

u/l

1.38

148

1113

Fall on and from stairs and steps

669

1.44

2.97

1.1

80.60

81.71

u/l

0.07

591

Diaphragmatic hernia

143

1066

1.34

2.97

1.1

77.50

85.16

u/l

1.04

125

940

Dorsopathies

360

1503

1.21

2.96

1.2

1.1

80.92

84.73

u/l

0.38

321

1341

Inflammatory diseases of female pelvic organs

244

1330

1.26

2.92

1.2

1.1

72.09

77.48

u/l

0.94

206

1198

Visual disturbances and blindness

199

1555

1.28

2.92

1.2

1.1

84.25

82.35

u/l

0.10

179

1383

Benign neoplasm: Small intestine

2.33

2.91

1.1

1.2

76.79

84.19

u/l

0.21

Disorders of adult personality and behaviour

614

1.45

2.91

1.2

89.44

77.94

u/l

0.34

560

Nonorganic sleeping disorders, excluding more controls

420

1.55

2.91

1.2

1.1

89.76

81.88

u/l

0.25

381

Delirium, not induced by alcohol and other psychoactive substances

280

1.68

2.89

1.2

1.1

78.44

86.88

u/l

0.45

249

Factitial dermatitis

6.83

2.89

1.2

97.50

76.89

u/l

—

Microscopic polyangiitis

6.82

2.88

1.5

1.2

56.00

76.67

u/l

—

Sulfonylureas

121

698

1.38

2.88

1.1

1.2

101.29

83.67

u/l

1.08

108

609

Other intervertebral disc disorders

298

1446

1.23

2.87

1.2

1.1

78.30

85.55

u/l

1.02

271

1290

Open wound of lower leg

335

1.62

2.87

1.1

119.50

85.49

u/l

0.70

298

Epilepsy

103

731

1.41

2.85

1.1

88.17

83.22

u/l

0.25

646

Otitis media, unspecified

157

1.88

2.83

1.3

1.2

80.03

73.18

u/l

0.27

142

Care involving use of rehabilitation procedures

213

1515

1.26

2.82

1.2

1.1

87.06

80.33

u/l

0.67

186

1338

Other extrapyramidal and movement disorders in other diseases

685

1.42

2.82

1.1

69.46

84.37

u/l

2.34

612

Poisoning by drugs, medicaments and biological substances

521

1.48

2.80

1.2

74.76

78.71

u/l

0.27

472

Colonic or urogenital fistula

678

1.42

2.79

1.1

78.57

85.19

u/l

0.49

606

Calculus of kidney and ureter

104

745

1.40

2.79

1.2

1.1

81.56

88.88

u/l

0.57

667

Corneal ulcer

433

1.53

2.78

1.2

85.03

84.15

u/l

0.03

389

Other viral diseases, not elsewhere classified

376

1.57

2.78

1.2

1.1

74.80

83.54

u/l

0.52

340

Osteomyelitis of vertebra

8.61

2.77

1.2

1.3

96.20

75.17

u/l

—

Other or unspecified immunodeficiency

8.57

2.77

1.2

52.20

61.35

u/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

5.10

2.74

1.0

1.2

128.14

62.58

u/l

—

Superficial injury of ankle and foot

240

1.71

2.73

1.3

1.1

79.01

73.28

u/l

0.22

221

Unspecified acute lower respiratory infection

309

1.62

2.72

1.1

101.20

85.57

u/l

0.40

281

Benign intracranial hypertension

6.07

2.70

1.2

1.0

71.00

76.21

u/l

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.26

2.69

1.1

1.2

97.50

83.22

u/l

—

Dizziness and giddiness

282

1797

1.22

2.68

1.1

89.37

82.60

u/l

0.52

248

1606

Fracture at wrist and hand level

115

841

1.37

2.68

1.1

1.2

89.33

85.70

u/l

0.12

101

756

Speech and linguistic disorders

120

2.00

2.67

1.2

77.93

79.93

u/l

0.06

105

Dislocation, sprain and strain of joint and ligaments of hip

2.34

2.65

1.2

1.1

118.18

84.44

u/l

0.35

Disorder of lipoprotein metabolism, unspecified

288

1.64

2.65

1.1

91.60

84.38

u/l

0.23

254

Other and unspecified disorders of vitreous body

173

1319

1.28

2.63

1.2

1.1

81.02

84.36

u/l

0.22

158

1163

Restless leg syndrome

351

1.57

2.63

1.1

70.22

79.08

u/l

0.73

316

Fibroblastic disorders

578

1.44

2.63

1.2

1.1

80.93

89.56

u/l

0.53

517

Disorders of breast

194

1349

1.27

2.62

1.1

74.60

77.65

u/l

0.34

172

1206

Schizophrenia or delusion, excluding more controls

645

1.41

2.61

1.2

75.89

80.62

u/l

0.35

581

Pre-eclampsia or eclampsia

563

1.44

2.59

1.1

1.2

79.02

75.20

u/l

0.21

511

Urolithiasis

110

807

1.37

2.58

1.2

1.1

80.15

87.63

u/l

0.63

719

Other bursopathies

306

1.61

2.57

1.3

1.1

70.76

83.36

u/l

0.92

273

Migraine

170

1029

1.29

2.56

1.2

72.55

78.54

u/l

0.85

162

916

Severe visual impairment, binocular

7.28

2.56

1.0

1.1

58.20

60.43

u/l

—

Use of anticholinesterases

795

0.69

2.55

1.0

1.1

87.12

87.90

u/l

0.03

682

N06DA Anticholinesterases

795

0.69

2.55

1.0

1.1

87.12

87.90

u/l

0.03

682

COPD

162

1019

1.29

2.55

1.2

1.1

91.23

86.47

u/l

0.30

143

895

Dental pulpitis, including avohilmo

325

1736

1.20

2.53

1.2

75.74

83.05

u/l

1.37

290

1558

Other blood glucose lowering drugs, excl. Insulins

381

1.53

2.47

1.0

1.1

86.25

81.10

u/l

0.21

332

Hypertrophy of breast in women and men

536

1.44

2.47

1.1

1.2

74.09

78.07

u/l

0.38

488

Deforming dorsopathies

106

780

1.36

2.45

1.2

1.1

74.58

84.30

u/l

1.25

690

Amyloidosis

2.57

2.45

1.2

169.46

86.52

u/l

0.49

Systemic lupus erythematosus

2.25

2.44

1.1

1.2

90.00

78.79

u/l

0.40

Dentofacial anomalies [including malocclusion]

250

1602

1.22

2.43

1.2

1.1

76.25

82.00

u/l

0.67

221

1441

Other viral diseases, including avohilmo

117

867

1.34

2.43

1.2

1.1

82.29

79.75

u/l

0.15

106

784

Postmenopausal atrophic vaginitis

112

448

1.37

2.41

1.1

75.21

82.88

u/l

0.73

402

Vulvovaginal ulceration/inflammation in other diseases

138

1.89

2.41

1.1

87.81

68.98

u/l

0.91

132

Hyperplasia of prostate

105

430

1.38

2.40

1.1

1.2

78.19

97.94

u/l

2.20

387

Other arthrosis

188

999

1.26

2.40

1.1

81.75

85.87

u/l

0.33

173

891

Other disorders of breast

352

1.54

2.39

1.1

1.2

72.69

72.86

u/l

0.01

317

Hypertrophy of breast

482

1.46

2.39

1.1

69.20

74.96

u/l

0.91

437

Corticotropin deficiency

4.18

2.37

1.3

1.2

233.43

102.82

u/l

—

Alcohol abuse, main dg, excluding more controls

266

1.62

2.37

1.1

92.49

86.40

u/l

0.15

240

Postmenopausal bleeding

115

445

1.36

2.36

1.1

71.94

83.63

u/l

1.48

104

399

Asthma/COPD (KELA code 203)

334

1883

1.19

2.33

1.1

77.01

82.74

u/l

0.93

303

1678

FESS (DNB20)

276

1.60

2.30

1.1

85.17

79.78

u/l

0.23

252

Disorders of ocular muscles, binocular movement, accommodation and refraction

164

1284

1.27

2.30

1.2

1.1

74.89

81.33

u/l

0.65

148

1148

Ovarian cyst

122

524

1.33

2.30

1.2

1.1

73.16

80.06

u/l

0.74

111

471

Sciatica+with lumbago

187

1326

1.25

2.30

1.1

75.17

85.36

u/l

1.19

169

1185

Pneumonia derived septicemia

2.39

2.29

1.1

1.2

74.43

88.52

u/l

0.50

Rotator cuff syndrome

219

1225

1.23

2.29

1.2

1.1

76.99

86.13

u/l

1.22

200

1086

Macular pucker

421

1.48

2.28

1.2

1.1

89.41

83.84

u/l

0.28

363

Early onset COPD

570

1.41

2.28

1.2

1.1

87.93

88.92

u/l

0.04

508

Other chronic obstructive pulmonary disease, including avohilmo

195

1290

1.24

2.26

1.2

1.1

85.46

85.84

u/l

0.03

170

1141

Mental and behavioural disorders due to alcohol, excluding acute intoxication

143

1104

1.29

2.26

1.2

1.1

106.23

83.65

u/l

1.12

124

994

Symptoms and signs involving speech and voice

125

957

1.31

2.25

1.1

75.37

82.42

u/l

0.68

112

846

Unknown and unspecified causes of morbidity

120

1.92

2.25

1.2

1.1

78.18

75.86

u/l

0.09

111

Benign neoplasm: Skin, unspecified

2.16

2.25

1.4

1.2

82.00

79.40

u/l

0.06

Injury, poisoning and certain other consequences of external causes

175

693

1.27

2.23

1.2

1.1

74.84

81.29

u/l

0.68

159

623

Cardiomyopathy in other diseases

5.65

2.22

1.2

1.0

130.60

178.11

u/l

—

Polycythaemia vera

2.35

2.22

1.1

1.2

96.21

78.28

u/l

0.45

Benign neoplasm: Descending colon

157

1.79

2.21

1.2

1.1

94.29

84.85

u/l

0.33

138

Other specified disorders of external ear

2.20

2.21

1.1

1.2

144.77

89.81

u/l

0.38

Spondylosis

205

1301

1.23

2.20

1.2

1.1

85.98

86.68

u/l

0.03

173

1156

Primary open-angle glaucoma

118

865

1.31

2.20

1.2

1.1

74.07

87.42

u/l

2.08

763

Other predominantly sexually transmitted diseases, not elsewhere classified

344

1.51

2.18

1.2

1.1

89.86

72.35

u/l

0.74

317

Specific development disorders of speech and language

2.13

2.17

1.2

85.12

84.73

u/l

0.01

Other enthesopathies

107

806

1.33

2.17

1.2

1.1

72.03

82.82

u/l

0.79

725

Other anxiety disorders

145

966

1.28

2.17

1.1

1.2

93.42

77.74

u/l

0.72

128

874

Convulsions, not elsewhere classified

437

1.45

2.16

1.1

85.98

77.23

u/l

0.70

399

Menorrhagia

121

513

1.32

2.12

1.2

1.1

70.22

80.63

u/l

1.61

111

463

Acute alcohol intoxication, ICD10

412

1.46

2.11

1.1

96.02

88.54

u/l

0.25

379

Other symptoms and signs involving cognitive functions and awareness

174

1240

1.24

2.10

1.1

88.79

83.87

u/l

0.22

150

1098

Diseases of middle ear and mastoid

181

1192

1.24

2.10

1.2

1.1

95.35

81.33

u/l

0.79

170

1066

Mixed conductive and sensorineural hearing loss

284

1.55

2.08

1.1

68.05

83.96

u/l

0.92

248

Ethmoidectomy

284

1.55

2.07

1.1

85.17

82.18

u/l

0.11

259

Necrosis of pulp, including avohilmo

203

1645

1.22

2.07

1.2

73.36

82.17

u/l

1.67

181

1474

In situ neoplasms

148

1173

1.26

2.07

1.2

1.1

79.27

83.59

u/l

0.42

136

1030

Vasomotor and allergic rhinitis

124

939

1.29

2.06

1.1

1.2

75.62

80.70

u/l

0.40

117

843

Congenital malformations and deformations of the musculoskeletal system

145

1.79

2.06

1.1

1.2

78.46

78.11

u/l

0.01

134

Other chronic obstructive pulmonary disease

151

979

1.26

2.06

1.2

1.1

87.28

86.80

u/l

0.03

132

857

Other immunodeficiencies

4.04

2.04

1.2

1.1

69.50

87.47

u/l

—

Unstable angina pectoris

123

747

1.29

2.03

1.1

83.00

82.61

u/l

0.02

112

646

Coronary artery bypass grafting

436

1.38

2.02

1.2

1.1

104.76

84.23

u/l

0.61

382

Disturbances of skin sensation

695

1.34

2.02

1.2

1.1

70.31

81.65

u/l

1.18

621

Pre-eclampsia or poor fetal growth

101

761

1.32

2.01

1.2

78.14

73.44

u/l

0.34

693

Seborrhoeic keratosis

722

1.33

2.00

1.2

1.1

76.02

80.86

u/l

0.29

628

Asthma, hospital admissions , main diagnosis only

288

2126

1.18

2.00

1.1

1.2

80.84

83.48

u/l

0.26

263

1889

Persistent mood disorders

442

1.43

2.00

1.2

72.26

83.86

u/l

0.86

396

Cardiomyopathy

343

1.49

2.00

1.1

87.47

83.06

u/l

0.20

302

Lichen sclerosus et atrophicus

303

1.52

2.00

1.1

79.55

77.42

u/l

0.11

268

Excessive, frequent and irregular menstruation

129

533

1.29

1.99

1.2

1.1

64.90

79.82

u/l

3.20

113

480

Hernia

335

1908

1.17

1.99

1.1

87.78

83.36

u/l

0.38

299

1701

Injuries to the wrist and hand

361

2064

1.16

1.98

1.1

83.85

82.54

u/l

0.10

322

1842

Atrophic disorders of skin

410

1.44

1.97

1.1

80.84

76.64

u/l

0.27

363

Infections with a predominantly sexual mode of transmission, including avohilmo

118

836

1.29

1.97

1.2

97.63

74.35

u/l

1.25

105

766

Viral warts, including avohilmo

502

1.40

1.97

1.2

1.1

71.38

81.45

u/l

0.97

451

SLE, ICD10

2.09

1.97

1.1

1.2

90.19

80.29

u/l

0.32

SLE, strict definition

2.09

1.97

1.1

1.2

90.19

80.29

u/l

0.32

Erosion of teeth , including avohilmo

630

1.35

1.96

1.2

87.51

80.85

u/l

0.27

572

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

699

1.33

1.95

1.1

1.2

73.33

84.77

u/l

1.12

633

Use of pramipexole

605

1.36

1.95

1.1

70.09

85.41

u/l

1.75

533

Explicit fungal Sepsis

4.61

1.95

1.0

146.40

121.45

u/l

—

Explicit fungal Sepsis, including avohilmo

4.61

1.95

1.0

146.40

121.45

u/l

—

Wet age-related macular degeneration

428

1.42

1.95

1.1

92.27

86.85

u/l

0.23

374

Alcohol use disorder, ICD-based

130

1024

1.27

1.94

1.2

1.1

108.63

83.84

u/l

1.12

112

919

Other inflammation of eyelid

363

1.46

1.92

1.2

1.1

72.70

83.05

u/l

0.68

324

Benign neoplasm of eye and adnexa

258

1.56

1.92

1.1

105.16

78.13

u/l

1.04

231

Strabismus

631

1.35

1.91

1.1

1.2

75.98

82.34

u/l

0.46

564

Transient ischemic attack

187

1220

1.22

1.91

1.1

89.06

82.80

u/l

0.36

165

1087

Pollen allergy

350

1.47

1.91

1.1

1.2

76.17

72.95

u/l

0.20

320

Angina pectoris

193

1051

1.22

1.88

1.1

94.72

81.30

u/l

0.82

177

927

Triptan medication for migraine, single purchase ok

263

1507

1.18

1.87

1.1

1.2

75.91

82.86

u/l

0.92

243

1346

Migraine, single triptan purchase ok & required. ICD-code if available is included

263

1507

1.18

1.87

1.1

1.2

75.91

82.86

u/l

0.92

243

1346

Other obstetric conditions, not elsewhere classified

366

1.36

1.82

1.1

1.2

79.39

71.34

u/l

0.80

342

Personal history of malignant neoplasm

206

1.61

1.82

1.3

1.1

60.36

73.94

u/l

1.32

188

Conjunctivitis

263

1799

1.18

1.82

1.2

1.1

77.16

83.31

u/l

0.79

248

1597

Use of other anti-dementia drugs

625

0.71

1.80

1.1

86.68

88.98

u/l

0.09

538

Use of memantine

625

0.71

1.80

1.1

86.68

88.98

u/l

0.09

538

Open wound of wrist and hand

138

1068

1.25

1.80

1.2

87.46

86.42

u/l

0.04

124

965

Diffuse large B-cell lymphoma, including Hilmo

1.96

1.80

1.1

116.88

90.46

u/l

0.74

Diffuse large B-cell lymphoma, helper endpoint

1.96

1.80

1.1

116.88

90.46

u/l

0.74

Diffuse large B-cell lymphoma

1.96

1.80

1.1

116.88

90.46

u/l

0.74

Malignant neoplasm of corpus uteri, including Hilmo

216

1.58

1.76

1.2

1.1

77.47

73.00

u/l

0.20

182

Emotionally unstable personality disorder

216

1.58

1.76

1.3

1.1

69.96

74.04

u/l

0.23

204

Peritonsillar abscess

429

1.40

1.75

1.2

68.90

82.31

u/l

1.32

389

Car occupant injured in other and unspecified transport accidents

404

1.41

1.75

1.1

85.88

78.13

u/l

0.32

366

Personal history of risk-factors, not elsewhere classified

3.36

1.75

1.7

1.2

61.83

118.98

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

396

1.42

1.74

1.2

87.27

73.19

u/l

0.59

366

Ulcer of oesophagus

117

1.80

1.74

1.2

82.38

91.03

u/l

0.31

106

Hallux valgus (acquired)

121

683

1.27

1.73

1.1

72.97

83.92

u/l

1.44

104

606

Other factor of the environment

2.94

1.73

1.0

1.1

55.57

93.50

u/l

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

200

1.59

1.72

1.1

1.2

89.53

73.38

u/l

0.53

184

Contact with other and unspecified heat and hot substances

3.90

1.72

1.0

1.2

138.00

84.01

u/l

—

Acute drug-induced interstitial lung disorder

3.89

1.72

1.2

1.3

80.00

98.38

u/l

—

Other secondary gonarthrosis

118

1.79

1.70

1.3

1.2

73.62

77.65

u/l

0.16

109

Pregnancy hypertension

143

1035

1.24

1.69

1.1

1.2

76.03

74.17

u/l

0.16

131

934

Trochanteric bursitis

382

1.42

1.69

1.1

65.42

79.59

u/l

1.57

338

Other condition

316

1.46

1.68

1.3

1.1

110.97

79.51

u/l

0.57

283

Visual disturbances

171

1415

1.21

1.67

1.2

1.1

85.29

82.78

u/l

0.11

151

1259

Melanocytic naevi, other sites/unspecified

172

1.63

1.67

1.3

1.1

67.11

78.58

u/l

0.57

158

Disorders of refraction and accommodation

689

1.30

1.67

1.3

1.2

75.59

80.01

u/l

0.24

618

Retinal detachments and breaks

123

984

1.25

1.66

1.2

1.1

78.05

82.62

u/l

0.29

110

869

Haemolytic anaemias

2.11

1.65

1.6

1.1

87.92

88.37

u/l

0.01

Injuries to the neck

528

1.35

1.65

1.1

74.77

81.86

u/l

0.45

476

Schizophrenia, schizotypal and delusional disorders

720

1.29

1.64

1.2

75.18

82.03

u/l

0.57

651

Lymphangioma, anys site

3.61

1.62

1.0

1.2

79.60

78.29

u/l

—

Umbilical hernia

634

1.31

1.62

1.2

1.1

97.08

87.40

u/l

0.29

564

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

116

913

1.26

1.61

1.1

1.2

79.54

77.46

u/l

0.12

104

833

Stomatitis and related lesions

479

1.36

1.61

1.1

78.63

82.42

u/l

0.19

424

Injury of nerves at forearm level

3.02

1.58

1.2

1.1

55.17

101.44

u/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

348

1.34

1.58

1.1

1.2

77.44

72.08

u/l

0.43

324

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

160

1148

1.21

1.56

1.1

1.2

74.43

75.88

u/l

0.13

147

1034

Bacterial pneumoniae

128

910

1.24

1.54

1.2

1.1

77.72

81.99

u/l

0.37

117

794

Pneumococcal septicemia

2.04

1.54

1.1

1.2

73.46

87.31

u/l

0.50

Complications of other internal prosthetic devices, implants and grafts

1.93

1.54

1.2

1.1

88.40

82.91

u/l

0.13

Schizophrenia or delusion

719

1.28

1.53

1.2

75.89

82.13

u/l

0.50

649

Atopic dermatitis

187

1252

1.19

1.52

1.2

1.1

74.27

81.48

u/l

0.91

173

1117

Myocardial infarction, with ST-elevation

383

1.39

1.50

1.1

96.76

93.54

u/l

0.11

335

COPD related to multimorbidity

134

925

1.23

1.49

1.2

1.1

89.45

88.03

u/l

0.09

119

811

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

443

1.36

1.49

1.3

1.2

76.74

73.09

u/l

0.28

406

Lumbar disc prolapse

220

1391

1.17

1.49

1.2

1.1

79.65

85.73

u/l

0.63

201

1242

Other or ill-defined heart diseases

101

1.79

1.48

1.3

1.1

105.98

78.85

u/l

0.75

Primary open-angle glaucoma, strict

747

1.27

1.48

1.2

1.1

76.52

85.22

u/l

0.97

656

Conjunctivitis (acute, non atopic)

693

1.28

1.48

1.3

1.1

79.51

82.40

u/l

0.14

614

Neuromuscular dysfunction of bladder

202

1.54

1.48

1.2

1.1

102.38

82.84

u/l

0.40

182

Allergic asthma (mode), excluding more controls

433

1.35

1.47

1.1

82.79

74.44

u/l

0.39

384

Other disorders of pigmentation

1.82

1.47

1.1

95.39

82.56

u/l

0.21

Oesophagitis

1.81

1.47

1.2

140.24

84.68

u/l

0.43

Female genital prolapse

108

477

1.26

1.46

1.1

70.15

82.28

u/l

1.46

431

Superficial injury of forearm

187

1.55

1.45

1.2

65.40

79.12

u/l

0.95

171

Nonischemic cardiomyopathy

203

1.53

1.45

1.0

1.1

80.16

86.40

u/l

0.23

177

Traction detachment of retina

3.16

1.44

1.0

1.3

83.60

81.13

u/l

—

Combinations of oral blood glucose lowering drugs

708

1.27

1.44

1.1

1.2

91.19

85.02

u/l

0.30

626

Lifestyle-related condition

2.75

1.44

1.0

1.1

60.00

98.27

u/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

559

1.31

1.43

1.1

85.35

81.54

u/l

0.19

500

Adenocarcinoma and papilloma adenocarcinoma of rectum

196

1.53

1.42

1.1

83.03

80.27

u/l

0.08

168

Chronic sinusitis

142

1177

1.21

1.40

1.1

78.54

82.99

u/l

0.36

125

1059

Adhesive capsulitis of shoulder

423

1.35

1.39

1.3

1.1

68.54

83.66

u/l

2.10

383

Diseases of male genital organs

128

525

1.23

1.38

1.1

1.2

96.14

94.27

u/l

0.06

115

475

Meniscus derangement

179

1004

1.18

1.37

1.1

81.17

85.97

u/l

0.42

152

897

Alcohol abuse, main dg

305

1.41

1.37

1.1

92.49

89.27

u/l

0.08

279

Behavioural syndromes associated with physiological disturbances and physical factors

328

1962

1.13

1.37

1.1

80.58

82.86

u/l

0.19

293

1755

Other female pelvic inflammatory diseases

433

1.34

1.37

1.1

1.2

62.16

73.91

u/l

1.33

391

Superficial injury of lower leg

678

1.27

1.37

1.1

1.2

96.71

82.13

u/l

0.83

602

Event of undetermined intent

120

1.67

1.34

1.1

1.2

69.28

83.39

u/l

0.66

114

Hydrocele

224

1.48

1.33

1.1

89.70

103.52

u/l

0.45

202

Other disorders of choroid

2.52

1.30

1.0

1.2

72.33

75.05

u/l

—

Nontoxic multinodular goitre

524

1.30

1.1

73.42

81.35

u/l

0.81

463

Fracture of shoulder and upper arm

121

996

1.21

1.30

1.2

1.1

95.21

83.35

u/l

0.51

105

879

Sleep disorders

316

1929

1.13

1.29

1.2

1.1

80.92

83.27

u/l

0.19

281

1725

Villonodular synovitis (pigmented)

2.80

1.29

1.2

1.1

99.20

103.38

u/l

—

Pleural plaque without asbestos

1.89

1.28

1.4

1.2

113.85

104.78

u/l

0.08

Nonorganic sleeping disorders

499

1.30

1.28

1.2

89.76

81.87

u/l

0.25

451

Other strabismus

497

1.30

1.28

1.1

1.2

74.35

81.99

u/l

0.48

445

Other and unspecified tonsillitis

509

1.27

1.2

77.87

84.10

u/l

0.35

462

Acetic acid derivatives and related substances

346

1.27

1.25

1.1

1.2

93.12

91.46

u/l

0.04

306

Haemorrhage in early pregnancy

747

0.77

1.25

1.1

1.2

77.77

74.52

u/l

0.12

688

Excessive vomiting in pregnancy

154

1.56

1.25

1.1

65.29

67.71

u/l

0.14

140

Other disorders of eyelid

164

1317

1.18

1.25

1.1

73.11

86.68

u/l

2.57

147

1155

Any dementia

826

0.81

1.24

1.1

83.80

86.81

u/l

0.18

707

Allergic asthma (mode)

448

1.31

1.22

1.1

82.79

79.67

u/l

0.12

396

COPD, early/later onset

152

1080

1.18

1.22

1.2

1.1

87.18

87.02

u/l

0.01

133

947

Disorders of speech understanding and production

1.97

1.21

1.2

1.1

78.73

88.46

u/l

0.21

Atopic dermatitis, strict definition

640

1.25

1.20

1.2

79.40

76.43

u/l

0.14

581

Non-allergic asthma (mode), excluding more controls

370

1.34

1.20

1.1

94.41

79.23

u/l

0.45

323

Pterygium

1.88

1.18

1.2

68.17

91.56

u/l

0.68

Radial styloid tenosynovitis [de Quervain]

117

1.63

1.18

1.1

1.2

92.25

73.72

u/l

0.51

109

Fracture of skull and facial bones

480

1.29

1.17

1.2

1.1

93.28

80.10

u/l

0.71

432

Allergic rhinitis

702

1.24

1.17

1.1

1.2

73.88

75.92

u/l

0.16

635

Thoracic aortic aneurysm

307

1.37

1.17

1.1

102.58

83.22

u/l

0.61

273

Chronic rhinitis, nasopharyngitis and pharyngitis

105

865

1.21

1.17

1.2

1.1

76.04

83.86

u/l

0.79

774

Later onset COPD, excluding more controls

378

1.29

1.16

1.2

1.1

87.02

84.23

u/l

0.12

317

Nonsuppurative otitis media, including avohilmo

591

1.24

1.16

1.2

97.47

76.83

u/l

0.66

529

Phakomatoses, not elsewhere classified

2.52

1.15

1.4

1.2

144.80

94.09

u/l

—

COPD, hospital admissions

150

1076

1.17

1.14

1.2

1.1

87.58

87.04

u/l

0.03

132

942

Other enthesopathy of foot (+metatarsalgia)

241

1.41

1.13

1.4

1.2

62.14

79.51

u/l

1.47

219

Bacterial pneumonia (organism specified)

144

1109

1.18

1.13

1.2

1.1

79.58

84.05

u/l

0.41

133

970

Leiomyoma of uterus

234

1153

1.14

1.12

1.1

74.82

78.40

u/l

0.35

211

1028

Noninflammatory disorders of female genital tract

127

533

1.20

1.11

1.1

71.42

79.82

u/l

0.96

114

480

Myopia

259

1.39

1.11

1.4

1.2

86.01

74.95

u/l

0.26

240

Benign neoplasm: Skin of other and unspecified parts of face

243

1.40

1.09

1.2

61.33

82.31

u/l

2.09

218

Endometriosis of intestine

2.39

1.09

1.0

1.1

91.20

71.43

u/l

—

Disorders of tooth development and eruption

259

1.35

1.09

1.2

1.1

69.07

84.76

u/l

1.34

238

Chronic conjunctivitis

1.83

1.09

1.3

1.1

55.36

82.69

u/l

1.58

Use of donepezil

523

0.75

1.08

1.0

1.1

76.91

88.91

u/l

0.45

451

Malignant neoplasm of stomach, including Hilmo

1.65

1.06

1.1

75.88

87.65

u/l

0.39

Spirochaetal infections, other/unspecified, including avohilmo

992

0.82

1.06

1.2

1.1

76.38

82.73

u/l

0.52

881

Palmar fascial fibromatosis [Dupuytren]

339

1.33

1.06

1.2

1.1

77.80

92.07

u/l

0.85

303

Hallux rigidus

348

1.32

1.05

1.1

76.61

86.76

u/l

0.58

304

Obstructed labour due to malposition and malpresentation of fetus

485

1.26

1.05

1.2

69.79

75.56

u/l

0.58

451

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

179

1494

1.15

1.05

1.2

1.1

77.48

80.90

u/l

0.30

169

1329

Varicose veins

224

1494

1.13

1.05

1.1

81.57

83.18

u/l

0.15

193

1338

Superficial injury of abdomen, lower back and pelvis

331

1.33

1.04

1.1

71.66

81.84

u/l

0.72

297

Extrapyramidal and movement disorders

132

1126

1.17

1.04

1.1

70.54

84.28

u/l

2.63

108

1000

Melanocytic naevi

814

1.21

1.04

1.3

1.1

73.82

81.60

u/l

0.74

728

Single spontaneous delivery

630

0.83

1.04

1.1

1.2

63.87

82.98

u/l

3.40

556

Injuries to the shoulder and upper arm

297

2059

1.11

1.03

1.2

1.1

90.74

83.05

u/l

0.61

263

1837

Schizophrenia

332

1.33

1.03

1.1

76.05

81.37

u/l

0.23

302

Vascular dementia (mixed)

2.07

1.03

1.3

1.1

88.29

118.22

u/l

—

ILD-related respiratory insufficiency

1.84

1.03

1.5

1.2

90.64

94.58

u/l

0.07

Benign neoplasm: Rectum, anus and anal canal

535

1.25

1.03

1.2

1.1

81.23

84.79

u/l

0.16

474

Lyme disease

988

0.82

1.03

1.2

1.1

76.38

82.60

u/l

0.50

877

Lyme disease, including avohilmo

988

0.82

1.03

1.2

1.1

76.38

82.60

u/l

0.50

877

Other intracranial haemorrhages

1.89

1.01

1.6

1.2

73.30

88.63

u/l

—

Disorder of the sleep-wake schedule

2.01

1.00

1.4

1.2

57.14

92.76

u/l

—

Injury of eye and orbit

282

1.35

0.99

1.1

129.02

81.99

u/l

0.72

258

Other spirochaetal diseases

995

0.82

0.99

1.2

1.1

76.86

82.65

u/l

0.46

883

Sequelae of other external causes

115

1.57

0.99

1.2

1.1

142.33

82.41

u/l

0.63

108

Benign neoplasm: Sigmoid colon

502

1.26

0.99

1.3

1.1

88.91

88.27

u/l

0.02

445

Blepharochalasis

108

911

1.19

0.98

1.1

69.94

83.87

u/l

2.08

804

Other noninflammatory disorders of uterus, except cervix

429

1.23

0.98

1.2

1.1

76.59

82.53

u/l

0.39

385

Other benign neoplasms of skin

124

1059

1.17

0.98

1.2

1.1

82.62

82.51

u/l

0.00

112

936

Other spirochaetal diseases, including avohilmo

1003

0.83

0.97

1.2

1.1

76.70

82.52

u/l

0.47

891

Insomnia

304

1910

1.11

0.97

1.2

1.1

79.77

83.40

u/l

0.31

270

1709

Aortic aneurysm

520

1.25

0.97

1.1

99.59

84.59

u/l

0.73

453

Oral lichen planus, including avohilmo , including avohilmo

190

1.42

0.96

1.2

86.86

72.56

u/l

0.92

172

Herpesviral [herpes simplex] infections, including avohilmo

631

1.22

0.95

1.2

1.1

86.74

80.01

u/l

0.34

570

Alcohol dependence

604

1.23

0.95

1.2

1.1

118.37

84.32

u/l

0.86

543

Other fall from one level to another

478

1.26

0.95

1.1

88.01

86.49

u/l

0.04

426

Medical abortion

221

1062

1.13

0.94

1.1

77.47

76.56

u/l

0.08

198

949

Right hemicolectomy

125

1.52

0.94

1.2

1.1

130.32

89.13

u/l

0.63

111

Lichen ruber planus, wide definition including periferal and oral lichen planus

633

1.22

0.93

1.2

1.1

74.15

81.74

u/l

0.60

564

Retained placenta and membranes, without haemorrhage

321

1.31

0.92

1.1

1.2

74.60

75.31

u/l

0.03

290

Tinnitus

607

1.22

0.92

1.2

1.1

76.58

82.91

u/l

0.54

533

Other viral diseases, not elsewhere classified, including avohilmo

603

1.22

0.92

1.2

1.1

76.09

80.94

u/l

0.31

545

Tularaemia

2.16

0.91

1.0

1.2

92.83

92.39

u/l

—

Retinal detachment with retinal break

313

1.31

0.91

1.1

71.88

84.89

u/l

0.81

278

Dermatophytosis, including avohilmo

214

1871

1.12

0.91

1.1

1.2

80.42

82.19

u/l

0.10

188

1676

Glaucoma, exfoliation

262

1.34

0.89

1.3

1.1

67.94

84.83

u/l

1.39

234

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

201

1389

1.12

0.88

1.2

1.1

77.13

79.58

u/l

0.24

177

1247

Benign neoplasm: Vulva

1.87

0.87

1.0

1.1

53.75

67.23

u/l

—

Carcinoma in situ of skin of lower limb, including hip

1.83

0.86

1.4

1.2

82.38

95.66

u/l

—

Malignant neoplasm of corpus uteri

195

1.39

0.86

1.2

1.1

74.46

71.07

u/l

0.15

162

Small cell lung cancer, including Hilmo

1.82

0.86

1.0

1.2

144.00

80.03

u/l

—

Small cell lung cancer

1.82

0.86

1.0

1.2

144.00

80.03

u/l

—

Polycystic ovarian syndrome

1.67

0.85

1.1

65.67

71.99

u/l

0.26

Endometriosis ASRM stages 3,4

595

1.21

0.85

1.1

1.2

78.08

74.24

u/l

0.31

530

Acne vulgaris

120

1.50

0.84

1.4

1.2

68.22

75.70

u/l

0.39

108

Malignant neoplasm of stomach

1.59

0.84

1.1

76.15

88.20

u/l

0.37

Allergic conjunctivitis

186

1593

1.12

0.84

1.2

1.1

76.68

80.63

u/l

0.38

176

1416

Other and unspecified nonorganic psychotic disorders

380

1.26

0.83

1.2

72.28

79.02

u/l

0.45

347

Delivery

102

630

0.85

0.83

1.1

1.2

60.62

82.98

u/l

5.39

556

Tonsillectomy and adenotomy

122

978

0.87

0.82

1.2

76.84

78.96

u/l

0.12

110

888

Pedal cyclist injured in transport accident

545

0.79

0.82

1.2

1.1

96.89

81.31

u/l

0.41

490

Glaucoma suspect

126

1097

1.15

0.81

1.2

1.1

76.35

84.70

u/l

0.99

105

979

Lichen planus, including avohilmo

526

1.22

0.81

1.2

1.1

72.36

82.31

u/l

0.74

470

Other disorders of veins

146

1265

1.14

0.80

1.2

1.1

92.28

82.56

u/l

1.11

124

1138

Transport accidents

139

1014

1.14

0.80

1.2

1.1

85.57

78.92

u/l

0.42

122

916

Achilles tendinitis

268

1.31

0.79

1.2

1.1

74.94

85.95

u/l

0.52

242

Oxicams

328

1.21

0.79

1.1

89.96

92.96

u/l

0.09

288

Preterm labour and delivery

729

1.18

0.79

1.1

1.2

76.56

75.59

u/l

0.06

662

Soft tissue disorders related to use, overuse and pressure

748

1.18

0.78

1.1

93.40

85.53

u/l

0.22

665

Pain and other conditions associated with female genital organs and menstrual cycle

433

1.22

0.78

1.1

79.02

74.29

u/l

0.21

392

Complications associated with artificial fertilization

0.00

0.77

0.0

1.1

—

77.35

—

Effects of foreign body entering through natural orifice

529

1.21

0.77

1.3

1.1

92.85

87.39

u/l

0.11

469

Unspecified/other endometriosis

170

1.38

0.77

1.1

74.78

69.64

u/l

0.23

157

Other and unspecified glaucoma

157

1.40

0.76

1.1

80.88

84.15

u/l

0.11

142

Hypermetropia

140

1.43

0.76

1.1

1.2

83.55

80.26

u/l

0.11

128

Malignant neoplasm of larynx, including Hilmo

0.00

0.76

0.0

1.2

—

92.57

—

Complications of labour and delivery

208

1041

1.11

0.74

1.1

1.2

69.19

78.35

u/l

2.16

186

931

Non-allergic asthma (mode)

401

1.24

0.74

1.1

94.41

83.53

u/l

0.29

346

Multiple delivery

231

0.69

0.73

1.1

1.2

56.22

76.49

u/l

1.53

213

Conduct disorder

2.01

0.72

1.0

1.1

56.80

72.78

u/l

—

Rosacea

335

1.26

0.71

1.2

1.1

64.46

77.76

u/l

1.34

299

Diseases of appendix

239

1950

1.10

0.71

1.2

77.76

83.63

u/l

0.94

210

1756

Metatarsalgia

229

1.31

0.71

1.3

1.2

61.68

78.28

u/l

1.24

207

Family history of other conditions

1.93

0.70

1.0

1.1

68.00

107.07

u/l

—

Benign lipomatous neoplasm

837

0.85

0.70

1.1

72.17

83.82

u/l

1.37

747

Cardiomyopathy, other and unspecified

143

1.40

0.70

1.0

1.1

86.19

81.36

u/l

0.13

130

Impingement syndrome of shoulder

619

1.18

0.69

1.1

90.37

87.48

u/l

0.06

553

Nontoxic goitre/thyroid nodule

861

1.15

0.69

1.1

70.46

79.91

u/l

1.51

767

Malignant neoplasm of eye, brain and central nervous system

1.60

0.68

1.3

1.1

104.91

82.53

u/l

0.21

Delivery, wide proxy

496

0.85

0.67

1.2

64.19

84.45

u/l

2.78

433

Alzheimer disease, excluding more controls

308

0.80

0.67

1.1

91.12

79.19

u/l

0.56

267

Benign neoplasm of brain and other parts of central nervous system

136

1.40

0.66

1.5

1.2

100.80

79.33

u/l

0.35

124

Ectopic pregnancy

495

0.81

0.66

1.1

76.63

74.94

u/l

0.07

455

Maternal care related to the fetus and amniotic cavity and possible delivery problems

118

783

0.88

0.65

1.1

1.2

70.76

73.06

u/l

0.27

107

713

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.62

0.65

1.1

103.70

97.55

u/l

—

Bacterial pneumonia, not elsewhere classified

112

866

1.14

0.65

1.1

77.20

80.66

u/l

0.28

103

753

Voice disturbances

763

1.15

0.65

1.1

71.68

83.05

u/l

1.20

674

Spondylolisthesis/Spondylolysis

513

1.19

0.65

1.1

74.55

82.62

u/l

0.67

454

1.54

0.64

1.1

80.42

92.82

u/l

0.34

Examination and encounter for administrative purposes

163

1.35

0.64

1.2

1.1

88.32

90.28

u/l

0.05

133

Periapical abscess

121

1361

0.89

0.64

1.2

1.1

95.25

83.55

u/l

0.50

107

1222

Lateral epicondylitis

323

1.24

0.63

1.2

1.1

78.23

80.44

u/l

0.05

296

Dementia

119

917

0.89

0.63

1.1

78.26

85.27

u/l

0.67

101

798

Any dementia, excluding more controls

731

0.87

0.63

1.1

81.55

83.92

u/l

0.14

629

Dislocation, sprain and strain of joints and ligaments at neck level

307

1.24

0.60

1.1

77.03

74.34

u/l

0.10

285

Ehlers-Danlos syndrome

0.00

0.60

0.0

1.2

—

80.71

—

All dysplastic lesions of the cervix uteri

630

0.84

0.59

1.1

1.2

74.34

73.02

u/l

0.07

582

Parkinson's disease, including avohilmo

389

0.80

0.59

1.2

1.1

73.45

87.27

u/l

0.74

340

Other lesions of median nerve

1.54

0.59

1.3

1.1

61.75

84.64

u/l

—

Acute alcohol intoxication

574

1.17

0.59

1.1

93.26

83.97

u/l

0.39

519

Female infertility

456

0.85

0.59

1.2

1.1

81.26

78.31

u/l

0.12

416

Atypical facial pain

114

1.41

0.58

1.3

1.2

73.00

75.32

u/l

0.06

104

Hemiplegia

1.46

0.58

1.0

1.2

68.15

84.99

u/l

0.50

Carcinoma in situ of skin of trunk

1.48

0.57

1.1

110.25

103.50

u/l

—

Pregnancy with abortive outcome

223

1069

1.09

0.56

1.2

1.1

72.51

76.56

u/l

0.60

200

955

Alzheimer’s disease (Early onset)

0.58

0.56

1.0

1.2

102.00

90.14

u/l

—

Gestational [pregnancy-induced] hypertension

604

1.16

0.56

1.1

1.2

70.93

73.01

u/l

0.18

547

Parkinson's disease

374

0.80

0.55

1.2

1.1

73.51

86.28

u/l

0.64

327

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

122

0.65

0.54

1.1

75.13

71.12

u/l

—

108

Localized swelling, mass and lump of skin and subcutaneous tissue

870

1.13

0.54

1.1

87.89

82.63

u/l

0.30

772

Benign neoplasm: Rectum

477

1.18

0.54

1.2

1.1

79.77

85.91

u/l

0.27

422

Fenamates

242

1.21

0.54

1.2

72.18

92.92

u/l

1.80

211

Polypectomy (DHB20)

126

0.63

0.54

1.0

1.2

62.34

91.27

u/l

—

116

Maternal care for other known or suspected fetal problems

287

1.18

0.52

1.2

71.07

72.48

u/l

0.10

267

malignant neoplasm of female genital organs, including Hilmo

412

1.18

0.52

1.2

1.1

88.32

72.95

u/l

1.15

350

Cyst of kidney

143

1.33

0.52

1.1

62.83

89.46

u/l

2.09

128

Injuries to unspecified part of trunk, limb or body region

205

1.27

0.52

1.2

87.43

79.51

u/l

0.33

185

Abnormal findings in secretions and smears from cervix uteri vagina vulva

138

1117

0.91

0.51

1.2

78.37

73.00

u/l

0.52

125

1008

Malignant neoplasm of mesothelium and soft tissue

1.41

0.51

1.1

148.33

94.21

u/l

—

Malignant neoplasm of brain, including Hilmo

1.47

0.50

1.3

1.1

114.09

80.62

u/l

0.35

Tularaemia, including avohilmo

1.47

0.50

1.0

1.1

92.83

95.07

u/l

—

Endometriosis

100

519

1.12

0.49

1.1

75.15

80.30

u/l

0.46

468

HSIL lesion of the cervix uteri, vagina or vulva

474

1.16

0.48

1.2

75.49

71.52

u/l

0.28

442

Salpingitis and oophoritis

540

1.15

0.47

1.0

1.2

79.78

75.70

u/l

0.22

493

Parkinson's disease, strict definition

343

0.82

0.46

1.1

75.03

86.92

u/l

0.53

303

Coxibs

351

1.14

0.46

1.1

1.2

86.10

91.00

u/l

0.12

311

Ocular pain

191

1.26

0.46

1.3

1.2

72.59

74.96

u/l

0.11

178

Antepartum haemorrhage, not elsewhere classified

153

0.72

0.45

1.0

1.2

69.09

74.43

u/l

0.27

144

Embedded teeth, including avohilmo

138

1.31

0.45

1.1

1.2

56.72

79.28

u/l

1.50

131

Chronic diseases of tonsils and adenoids

241

1421

1.07

0.45

1.2

74.98

83.75

u/l

1.43

219

1284

Carcinoma in situ of skin of scalp and neck

1.37

0.44

1.0

1.2

114.43

103.93

u/l

—

Propionic acid derivatives

357

1.13

0.44

1.2

86.70

89.70

u/l

0.12

317

Crowding of teeth, including avohilmo

105

0.71

0.44

1.2

55.44

76.07

u/l

—

Organic, including symptomatic, mental disorders

167

1086

1.08

0.43

1.1

80.06

86.04

u/l

0.65

143

953

Conjunctivitis (acute, non atopic), including avohilmo

332

1896

1.06

0.43

1.2

1.1

75.13

85.45

u/l

2.33

295

1681

Ingrowing nail

104

1.35

0.43

1.0

1.2

137.00

83.89

u/l

0.32

Injury of muscle and tendon at lower leg level

331

1.18

0.42

1.2

1.1

98.45

86.72

u/l

0.36

299

Appendicitis, broad definition

231

1944

1.07

0.42

1.2

77.22

83.65

u/l

1.05

202

1751

Struck by thrown, projected or falling objec

0.64

0.42

1.0

1.2

79.83

86.28

u/l

—

Right side

0.00

0.41

0.0

1.3

—

94.54

—

Coarctation of the aorta

0.00

0.41

0.0

1.2

—

89.14

—

Other and unspecified pemphigoid

0.00

0.41

0.0

1.3

—

111.19

—

COPD, hospital admission 2, with asthma infections

740

1.11

0.41

1.2

1.1

90.57

88.80

u/l

0.08

645

Unspecified maternal hypertension

0.00

0.40

0.0

1.2

—

94.94

—

Other congenital malformations of tongue, mouth and pharynx

0.00

0.40

0.0

1.1

—

57.88

—

Subjective visual disturbances

681

1.12

0.40

1.2

1.1

72.93

81.88

u/l

0.79

607

Dementia, including avohilmo

131

970

0.92

0.40

1.1

80.63

85.01

u/l

0.36

112

842

Melanocytic naevi of eyelid, including canthus

0.00

0.40

0.0

1.3

—

78.55

—

Injury of nerves at ankle and foot level

0.00

0.39

0.0

1.1

—

107.93

—

Frostbite

0.00

0.39

0.0

1.2

—

116.41

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

124

1.29

0.38

1.3

1.2

77.45

80.14

u/l

0.05

113

Crossbite

114

1.29

0.38

1.2

69.37

75.72

u/l

0.29

107

Acute appendicitis, no complications

165

1530

1.07

0.37

1.2

78.72

82.91

u/l

0.41

144

1381

Malignant neoplasm of rectum

197

1.22

0.37

1.0

1.1

80.71

86.39

u/l

0.17

169

Other orthopaedic follow-up care

114

0.70

0.37

1.6

1.1

92.88

75.96

u/l

—

104

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

116

1.29

0.37

1.1

120.83

85.67

u/l

0.54

100

Panniculitis affecting regions of neck and back

0.65

0.35

1.2

70.00

85.59

u/l

—

Gestational diabetes (for exclusion)

599

0.91

0.35

1.1

1.2

72.51

72.44

u/l

0.01

556

Adenocarcinoma and papillary adenocarcinoma of stomach

1.40

0.35

1.3

1.2

78.67

85.14

u/l

—

Benign mammary dysplasia

384

0.86

0.35

1.1

1.2

74.63

73.79

u/l

0.03

341

Other acquired deformities of musculoskeletal system and connective tissue

1.32

0.33

1.1

1.2

120.98

83.63

u/l

1.03

COPD, hospital admissions 3, with asthma pneumonia sepsis

591

1.10

0.33

1.2

1.1

84.29

93.08

u/l

0.52

517

Oter anti-inflammatory and antirheumatic agents, non-steroids

310

1.12

0.33

1.1

81.77

94.64

u/l

0.69

272

Chronic mastoiditis

1.31

0.33

1.5

1.1

239.33

90.49

u/l

—

Pemphigoid

1.28

0.32

1.0

1.1

70.00

105.33

u/l

—

Persons encountering health services in circumstances related to reproduction

174

1097

1.06

0.32

1.1

1.2

74.11

82.40

u/l

1.25

154

996

Appendectomy

198

1782

1.06

0.32

1.2

1.1

77.22

82.53

u/l

0.70

173

1604

Urethral stricture

101

1.29

0.31

1.0

1.1

114.14

108.31

u/l

—

Cervicalgia

560

1.11

0.31

1.2

1.1

90.09

83.72

u/l

0.23

496

Epiphora

1.35

0.31

1.0

1.2

64.00

88.43

u/l

—

Other abnormal products of conception

555

1.09

0.31

1.1

1.2

74.19

72.18

u/l

0.15

518

Redundant prepuce, phimosis and paraphimosis

374

1.13

0.31

1.1

1.2

95.33

100.01

u/l

0.15

341

Contraceptive management

122

795

1.07

0.30

1.2

71.87

81.10

u/l

1.17

109

725

Benign neoplasm: other/unspecified salivary gland

1.27

0.30

1.0

1.2

127.24

86.54

u/l

—

Failed induction of labour

1.31

0.30

1.1

1.2

70.82

75.73

u/l

0.19

Other maternal disorders predominantly related to pregnancy

168

1113

0.94

0.29

1.2

75.36

76.41

u/l

0.08

143

1012

Periodontal disease, other/unspecified

1.25

0.29

1.0

1.2

73.29

87.53

u/l

—

Inguinal hernia

139

983

0.94

0.29

1.1

95.43

87.74

u/l

0.41

121

867

Brain meningioma

109

0.73

0.29

1.0

1.2

91.13

68.65

u/l

—

Maternal care for known or suspected abnormality of pelvic organs

390

0.90

0.29

1.2

74.42

73.23

u/l

0.07

365

Acute appendicitis

213

1882

1.05

0.28

1.2

78.28

83.46

u/l

0.71

186

1693

Prolapse and hernia of ovary and fallopian tube

1.30

0.28

1.1

81.13

80.45

u/l

—

Subarachnoid haemorrhage

233

1.16

0.27

1.2

1.1

87.85

78.33

u/l

0.20

206

Other degenerative diseases of the nervous system

540

0.92

0.26

1.1

86.44

79.24

u/l

0.42

484

Pregnancy, childbirth and the puerperium

425

0.92

0.26

1.1

1.2

74.08

82.00

u/l

0.54

368

Use of ropinirole

0.70

0.26

1.0

1.2

120.60

84.48

u/l

—

Alzheimer’s disease (Early onset), excluding more controls

0.68

0.26

1.0

1.1

102.00

76.79

u/l

—

Triptan medication for migraine, min. 3 purchases

157

1236

0.95

0.25

1.2

73.06

77.06

u/l

0.40

147

1120

malignant neoplasm of female genital organs

369

1.11

0.25

1.2

1.1

87.14

73.09

u/l

0.89

309

Adverse effects, not elsewhere classified

464

1.10

0.24

1.1

1.2

92.44

74.90

u/l

0.89

417

Diabetes mellitus in pregnancy

465

1.08

0.24

1.2

81.25

72.31

u/l

0.81

436

Later onset COPD

622

0.93

0.23

1.2

1.1

86.30

88.76

u/l

0.12

539

Non-small cell lung cancer, squamous, helper endpoint

0.77

0.22

1.3

1.2

114.43

95.56

u/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

295

0.88

0.22

1.1

76.86

86.23

u/l

0.34

264

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

729

1.07

0.21

1.2

1.1

95.80

85.15

u/l

0.30

646

Benign neoplasm of major salivary glands

229

1.14

0.21

1.3

1.1

92.42

81.72

u/l

0.32

206

Carcinoma in situ of breast

0.00

0.21

0.0

1.3

—

57.45

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.2

—

63.79

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.21

0.0

1.2

—

121.28

—

Thiamine deficiency

0.00

0.21

0.0

1.2

—

90.60

—

Ovarian dysfunction, other/unspecified

0.00

0.21

0.0

1.3

—

74.10

—

COPD, hospital admissions 1, only main diagnosis

793

1.06

0.21

1.2

1.1

88.22

89.11

u/l

0.04

691

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.2

—

100.77

—

Unspecified parasitic disease

0.00

0.21

0.0

1.3

—

120.45

—

Effects of heat and light

0.00

0.21

0.0

1.2

—

101.91

—

Social disorders starting during childhood or adolescence

0.00

0.21

0.0

1.0

—

79.88

—

Arnold-Chiari syndrome

0.00

0.21

0.0

1.2

—

78.09

—

Other congenital malformations of nervous system

0.00

0.21

0.0

1.2

—

78.09

—

Other complications of labour and delivery, not elsewhere classified

148

0.84

0.21

1.1

1.3

59.62

73.22

u/l

0.60

139

Implicit parasitic Sepsis, including avohilmo

0.00

0.21

0.0

1.2

—

80.01

—

Superficial frostbite

0.00

0.21

0.0

1.2

—

97.40

—

Other and unspecified spinal muscular atrophies

0.00

0.21

0.0

1.2

—

130.00

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

1.2

—

51.41

—

Radiculopathy

411

1.10

0.21

1.2

1.1

86.50

85.36

u/l

0.04

368

Pediculosis and phthiriasis, including avohilmo

0.00

0.21

0.0

1.2

—

83.98

—

Endometriosis of fallopian tube

0.00

0.21

0.0

1.2

—

69.77

—

Unspecified parasitic disease, including avohilmo

0.00

0.21

0.0

1.2

—

109.54

—

Other bursitis of elbow

0.00

0.21

0.0

1.5

—

116.85

—

Unequal limb length (acquired)

0.00

0.21

0.0

1.0

—

120.81

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

0.00

0.21

0.0

1.2

—

55.38

—

Abrasion of teeth

114

1082

1.05

0.20

1.2

1.1

70.22

82.81

u/l

2.08

104

964

Other mosquito-borne viral fevers, including avohilmo

0.00

0.20

0.0

1.1

—

56.72

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.20

0.0

1.2

—

109.44

—

Gender identity disorders

0.00

0.20

0.0

1.0

—

91.61

—

Dysplasia of cervi uteri

440

0.93

0.20

1.1

75.30

74.96

u/l

0.02

400

Anti-inflammatory and antirheumatic products, non-steroids

357

1.07

0.20

1.1

1.2

82.46

89.70

u/l

0.35

317

Benign neoplasm of mouth and pharynx

259

1.12

0.20

1.1

1.2

76.42

80.44

u/l

0.14

233

Mouth breathing

109

1032

1.05

0.20

1.2

1.1

70.79

87.20

u/l

3.11

927

Renal cell carcinoma of kidney

1.18

0.19

1.2

1.1

56.17

84.02

u/l

—

Multiple gestation

186

0.86

0.19

1.1

1.2

68.41

74.71

u/l

0.27

175

Benign neoplasm of ovary

513

1.07

0.17

1.2

1.1

73.85

73.19

u/l

0.03

452

Benign neoplasm of other and unspecified sites

1.14

0.16

1.4

1.2

208.79

89.70

u/l

—

Other epidermal thickening

1.20

0.16

1.3

1.2

85.00

84.23

u/l

0.02

Retinal breaks without detachment

432

0.93

0.16

1.1

1.2

90.33

80.38

u/l

0.24

379

Endometriosis diagnosis and infertility diagnosis occurring together

224

0.89

0.15

1.1

67.00

69.70

u/l

0.17

210

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.81

0.14

1.9

1.2

134.29

85.47

u/l

—

Other menopausal disorders

457

0.95

0.14

1.2

1.1

78.51

80.32

u/l

0.07

413

Superficial injury of head

606

1.06

0.13

1.1

86.70

80.24

u/l

0.22

542

Chronic suppurative otitis media, including avohilmo

149

0.87

0.13

1.1

1.2

160.98

80.01

u/l

0.51

134

Additional codes for the location of defect, injury or illness

128

0.86

0.13

1.0

1.2

171.82

80.24

u/l

0.45

118

False labour

431

0.95

0.13

1.1

1.2

71.80

73.31

u/l

0.12

397

Brain meningioma, including Hilmo

109

0.82

0.13

1.0

1.2

203.00

68.65

u/l

—

Parkinson's disease, strict definition, excluding more controls

283

0.92

0.12

1.1

75.03

80.96

u/l

0.23

247

Chronic suppurative otitis media

127

0.87

0.12

1.1

179.18

81.70

u/l

0.52

113

Spontaneous abortion

133

919

0.97

0.12

1.1

1.2

81.77

75.74

u/l

0.72

120

831

Abnormal involuntary movements

317

1.07

0.12

1.1

79.30

81.82

u/l

0.09

284

Thiazolidinediones

259

1.08

0.11

1.0

1.2

105.78

77.13

u/l

0.84

232

Twin gestation

178

0.90

0.11

1.1

1.2

68.41

75.13

u/l

0.29

167

Caries of enamel

306

1963

1.02

0.11

1.2

1.1

78.61

83.33

u/l

0.55

273

1757

Stenosis and insufficiency of lacrimal passages

231

1.08

0.10

1.3

1.2

77.52

79.42

u/l

0.07

209

Other vitreous opacities

1.15

0.10

1.0

1.1

96.82

79.60

u/l

0.44

Parkinson's disease, excluding more controls

295

0.93

0.10

1.2

1.1

73.51

81.80

u/l

0.38

258

Premature rupture of membranes

311

1.05

0.09

1.2

67.50

71.80

u/l

0.41

294

Cervical disc disorders

1021

0.97

0.09

1.1

76.92

84.53

u/l

0.73

913

Other diseases of gallbladder

1.15

0.09

1.2

92.90

76.40

u/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.04

0.09

1.2

1.1

75.00

83.02

u/l

—

Complications predominantly related to the puerperium

696

0.96

0.09

1.2

83.97

73.59

u/l

0.61

631

Foreign body in respiratory tract

1.13

0.09

1.1

1.2

72.68

84.26

u/l

0.52

Adenocarcinoma and ductal carcinoma of pancreas

0.79

0.08

1.0

1.1

188.40

91.46

u/l

—

Respiratory tuberculosis, not confirmed

0.78

0.08

1.0

1.1

82.60

88.98

u/l

—

Respiratory tuberculosis, not confirmed, including avohilmo

0.78

0.08

1.0

1.1

82.60

88.98

u/l

—

Benign neoplasm: Parotid gland

185

1.08

0.08

1.3

1.2

75.08

78.34

u/l

0.11

167

Maternal care for other conditions predominantly related to pregnancy

477

1.04

0.08

1.1

1.2

76.66

72.74

u/l

0.28

448

Vascular dementia (subcortical)

1.04

0.08

1.1

106.29

104.66

u/l

—

Motorcycle rider injured in other and unspecified transport accidents

1.12

0.07

1.4

1.2

60.91

79.54

u/l

0.86

Traumatic amputation of wrist and hand

1.08

0.07

1.5

1.2

106.13

90.20

u/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

206

1.07

0.07

1.3

1.1

90.13

81.77

u/l

0.22

185

Congenital malformations of eye, ear, face and neck

102

0.88

0.06

1.3

1.2

68.67

81.36

u/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

731

0.97

0.06

1.2

78.17

71.83

u/l

0.56

668

Other osteochondropathies

130

1.08

0.04

1.2

58.10

83.19

u/l

1.93

124

HSIL lesion of the cervix uteri

403

0.97

0.04

1.2

71.37

71.83

u/l

0.02

377

Atopic conjunctivitis

1.09

0.03

1.1

59.39

84.08

u/l

—

Cervicobrachial syndrome

610

1.02

0.02

1.1

71.44

84.16

u/l

1.32

545

Transient global amnesia

232

1.03

0.02

1.1

80.84

79.54

u/l

0.04

205

Injury of other and unspecified intrathoracic organs

117

0.94

0.01

1.3

1.2

101.54

92.91

u/l

0.13

102

Foreign body entering into or through eye or natural orifice

146

0.96

0.00

1.4

1.2

70.00

84.21

u/l

0.61

136

Lesion of ulnar nerve

317

1.01

0.00

1.1

64.91

82.67

u/l

1.90

282

Acute appendicitis, with complications

481

1.00

0.00

1.1

76.78

85.73

u/l

0.80

434

Crushed, pushed or stepped on by crowd or human stampede

128

1.02

0.00

1.1

75.44

80.90

u/l

0.14

116

Vascular syndromes of brain in cerebrovascular disorders

101

0.99

0.00

1.2

1.1

62.00

92.38

u/l

—

Labour and delivery complicated by fetal stress [distress]

283

1.01

0.00

1.3

1.2

66.00

73.68

u/l

0.65

265

Dislocation, sprain and strain of joints and ligaments of knee

172

1554

1.00

0.00

1.1

1.2

77.18

80.55

u/l

0.41

162

1394

Other and unspecified effects of external causes

646

1.01

0.00

1.1

1.2

103.58

79.45

u/l

1.01

585

Glucosamine medication

151

1201

1.00

0.00

1.1

89.03

86.14

u/l

0.15

132

1052

Injury of muscle and tendon at shoulder and upper arm level

988

1.00

0.00

1.1

78.43

85.32

u/l

0.68

879

Other inflammation of eyelid, including avohilmo

127

1266

1.00

0.00

1.2

1.1

68.83

81.80

u/l

2.05

109

1138

Other and unspecified iridocyclitis

107

1.03

0.00

1.2

55.27

82.83

u/l

1.56

Carcinoma in situ of skin of lip

0.00

0.0

1.2

—

135.40

—

Acne varioliformis

0.00

0.0

1.0

—

65.22

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.0

1.0

—

124.01

—

Implicit parasitic Sepsis

0.00

0.0

1.1

—

92.89

—

Other congenital malformations of skull and face bones

0.00

0.0

1.2

—

42.38

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

0.0

1.3

—

178.33

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.3

—

55.89

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

0.0

1.3

—

57.85

—

Injury of nerves and spinal cord at thorax level

0.00

0.0

1.2

—

60.52

—

Open bite

0.97

0.00

1.0

1.2

92.44

80.16

u/l

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

1.0

—

90.73

—

Unspecified multiple injuries

0.00

0.0

1.0

—

50.82

—

Assault by hanging, strangulation and suffocation

0.00

0.0

1.0

—

133.40

—

Enterobiasis

0.00

0.0

1.2

—

68.60

—

Transient retinal artery occlusion

0.00

0.0

1.4

—

58.80

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.3

—

88.24

—

Femoral hernia, bilateral

0.00

0.0

1.4

—

88.87

—

Female infertility, uterine origin

0.00

0.0

1.1

—

77.25

—

Hypospadias

0.00

0.0

1.0

—

37.40

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.2

—

41.35

—

Frontotemporal dementia

0.00

0.0

1.3

—

125.50

—

Congenital aortic valve stenosis

0.00

0.0

1.0

—

39.40

—

Other and unspecified syphilis

0.00

0.0

1.2

—

54.02

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.2

—

55.17

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

1.1

—

118.96

—

Congenital malformations of oesophagus, including avohilmo

0.00

0.0

1.3

—

155.50

—

Other and unspecified parapsoriasis

0.00

0.0

1.4

—

58.88

—

Tooth agenesis EXCLUDE clefts and syndromes

0.91

0.00

1.2

1.1

83.20

85.35

u/l

—

Lesion of medial popliteal nerve

0.00

0.0

1.2

—

84.22

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.3

—

57.39

—

Abnormal findings in peritoneal fluid saliva

0.00

0.0

1.3

—

88.98

—

Other congenital malformations of integument, including avohilmo

0.00

0.0

1.2

—

115.22

—

Congenital hydrocephalus

0.00

0.0

1.1

—

88.87

—

Other fibroblastic disorders

0.00

0.0

1.2

—

83.33

—

Chromophobe cell carcinoma of kidney

0.00

0.0

1.1

—

107.44

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.0

—

90.10

—

Contact urticaria

0.00

-0.00

0.0

1.4

—

55.60

—

Acne keloid

0.00

-0.00

0.0

1.2

—

105.45

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

-0.00

0.0

1.2

—

56.20

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

1.3

—

87.29

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

60.71

—

Turner's syndrome

0.00

-0.00

0.0

1.0

—

59.22

—

Other and unspecified neuropathies

0.00

-0.00

0.0

1.3

—

107.17

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.2

—

136.02

—

Esophageal diverticulum (pouch), including avohilmo

0.00

-0.00

0.0

1.4

—

161.00

—

Other congenital malformations of male genital organs, including avohilmo

0.00

-0.00

0.0

1.1

—

45.86

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

-0.00

0.0

1.1

—

45.87

—

Radiodermatitis

0.00

-0.00

0.0

1.2

—

59.40

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

1.0

—

97.50

—

Acute hepatitis B

0.00

-0.00

0.0

1.0

—

72.22

—

Schistosomiasis [bilharziasis], including avohilmo

0.00

-0.00

0.0

1.2

—

43.40

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.2

—

56.52

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.0

—

141.74

—

Other cestode infections, including avohilmo

0.00

-0.00

0.0

1.4

—

61.14

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

1.2

—

54.02

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.1

—

100.53

—

Benign neoplasm: Heart

0.00

-0.00

0.0

1.3

—

88.00

—

Congenital ptosis

0.00

-0.00

0.0

1.0

—

56.20

—

Other cestode infections

0.00

-0.00

0.0

1.5

—

56.83

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

1.2

—

55.17

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.2

—

87.00

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.2

—

66.60

—

Marfan's syndrome

0.00

-0.00

0.0

1.3

—

60.73

—

Congenital varicose veins

0.00

-0.00

0.0

1.3

—

65.75

—

Acute hepatitis B, including avohilmo

0.00

-0.00

0.0

1.2

—

73.68

—

Syndactyly, including avohilmo

0.00

-0.00

0.0

1.3

—

70.14

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS